WO1996000392A1 - Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions - Google Patents

Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions Download PDF

Info

Publication number
WO1996000392A1
WO1996000392A1 PCT/US1995/007966 US9507966W WO9600392A1 WO 1996000392 A1 WO1996000392 A1 WO 1996000392A1 US 9507966 W US9507966 W US 9507966W WO 9600392 A1 WO9600392 A1 WO 9600392A1
Authority
WO
WIPO (PCT)
Prior art keywords
biacridine
analyte
εaid
binding partner
label
Prior art date
Application number
PCT/US1995/007966
Other languages
French (fr)
Inventor
George W. Katsilometes
Original Assignee
Katsilometes George W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katsilometes George W filed Critical Katsilometes George W
Priority to JP50334096A priority Critical patent/JP3989537B2/en
Priority to EP95924671A priority patent/EP0766825B1/en
Priority to DE69535764T priority patent/DE69535764D1/en
Publication of WO1996000392A1 publication Critical patent/WO1996000392A1/en
Priority to HK98100291A priority patent/HK1001416A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/802—Chromogenic or luminescent peptides

Definitions

  • the present invention relates to the synthesis of new 10,10'-substituted-9, / -biacridinium derivatives, the preparation of novel chemical solutions for the production of light from these new molecules, and the use of these new molecules in luminescent reactions and assays. More particularly, the invention describes the synthesis of the N-Hydroxysuccinimide derivative of 10,lO'-para-toluic acid-9,9'-biacridine and the demonstration of the ability to covalently bind (conjugate) this new molecule to another molecule such as an antibody and to produce measurable light from this bound chemiluminescent label molecule.
  • the invention further involves a luminescent signal solution comprising at least one oxidant, a sulfoxide, a chelating agent, a reducing sugar, and an alcohol in aqueous sodium tetraborate to produce high yield photon emissions useful in chemical assays, nucleic acid assays and immunoassay ⁇ .
  • a luminescent signal solution comprising at least one oxidant, a sulfoxide, a chelating agent, a reducing sugar, and an alcohol in aqueous sodium tetraborate to produce high yield photon emissions useful in chemical assays, nucleic acid assays and immunoassay ⁇ .
  • Luminescence is the production of light by any means, including photoexcitation or a chemical reaction.
  • Chemiluminescence is the emission of light only by means of a chemical reaction. It can be further defined as the emission of light during the reversion to the ground state of electronically excited products of chemical reactions ( oodhead, J.S. et al . , Complementary Immunoa ⁇ ays, W.P. Collins ed. , (John Wiley & Sons Ltd.), pp. 181-191 (1988)).
  • Chemiluminescent reactions can be divided into enzyme-mediated and nonenzymatic reactions.
  • the luminescent reactant luminol can be oxidized in neutral to alkaline conditions (pH 7.0 - 10.2) in the presence of oxidoreductase enzymes (horseradish peroxidase, xanthine oxidase, glucose oxidase) , H 2 0 2 , certain inorganic metal ion catalysts or molecules (iron, manganese, copper, zinc), and chelating agents, and that this oxidation leads to the production of an excited intermediate (3-aminophthalic acid) which emits light on decay to its ground state, (Schroeder, H.R. et al . , Anal . Chem . 48:1933-1937 (1976);
  • Additional molecules which produce light and have been utilized in the ultrasensitive measurement of molecules are polycyclic and reduced nitropolycyclic aromatic hydrocarbons, polycyclic aromatic amines, fluorescamine-labeled catecholamines, and other fluorescent derivatizing agents such as the coumarins, ninhydrins, o-phthalaldehydes, 7-fluoro-4- nitrobenz-2,1,3-oxadiazoles, naphthalene-2,3- dicarboxaldehydes, cyanobenz[f]isoindoles and da ⁇ syl chlorides (Simons, S.S., Jr.
  • the metalloporphyrins are small hapten molecules which decrease stearic hinderance problems in antigen binding.
  • the metalloporphyrin molecules known to be luminescent are those containing a paramagnetic metal ion with emission yields above 10" 4 (Gouterman, M. , The Porphyrin ⁇ , Vol. Ill, Dolphin, D. , ed. , (Academic Press): 48-50, 78-87, 115-117, 154-155 (1978); Canters, G.W and J.H. Van Der Waals, ibid, 577-578) .
  • metalloporphyrins hyposporphyrins, pseudonormal metalloporphyrins and metalloporphyrin-like molecules such as metallic chlorins, hemes, cytochromes, chlorophylls, lanthanides and actinides undergo oxidation/reduction reactions which are either primary or secondary to structural perturbations occurring in the metallic center of these molecules and that their reactive ability to catalyze the production of chemiluminescence has been ascribed to the metallo center of these molecules (Eastwood, D. and M. Gouterman, J . Mol . Spectros . 35:359-375 (1970); Fleischer, E.B. and M. Krishnamurthy, Annals N. Y. Academy of Sci .
  • the nonmetallic porphyrin deuteroporphyrin-IX HC1 has been shown to mediate the production of light from luminol in solution (Katsilo etes, G.W. , supra) .
  • lucigenin (10,10'-dimethyl-9,9'-biacridinium nitrate) has been extensively studied and has been ascribed to a series of hydroxide ion nucleophilic additions to acridinium salts and their reduction products (pinacols) , culminated by the oxidation of the main end product N-methylacridone (Janzen, E.G. et al . , J. Organic Chem . 35:88-95 (1970); Maeda, K. et al . , Bui . Chem . Soc . Japan 50:473-481 (1977); Maskiewicz, R. et al . , J. Am. Chem . Soc , 202/28:5347-5354 (1979); Maskiewicz, R. et al . ibid, 202/28:5355-5364 (1979)).
  • a luminescent derivative, a luminescent derivatized molecule or a derivatized luminescent molecule as defined herein is a molecule which results from the covalent binding of a functional group or a group which changes the chemical reactivity and properties of a precursor molecule leading to the formation of a luminescent molecule suitable for conjugation to an analyte or a particular binding partner one wishes to use in assay development.
  • a N-hydroxy succinimide derivatization of biacridines at one or both of the two 10,10' positions are the preferred luminescent derivatives of the invention.
  • a compound or a molecule is a "derivative" of a first compound or first molecule if the derivative compound or molecule is formed (or can be formed) by reaction of the first compound or first molecule to form a new compound or new molecule either smaller or larger than the first compound or first molecule while retaining at least part of the structure of the first compound or first molecule.
  • derivative can also include a "luminescent derivative”.
  • biacridines Prior to this invention, synthesis of derivatized luminescent 10,10'-substituted-9,9 , -biacridines has not been achieved.
  • the previously known luminescent biacridines e .g. , lucigenin
  • the biacridines have been of academic interest only and have been used to study the mechanism of light production and the interactions of reactive ionic species.
  • luminescent reactions at the surface of light conductive materials is the basis of the development of luminescent sensors or probes (Blum, L.J. et al . , Anal . Lett . 22:717-726 (1988)).
  • This luminescence may be modulated by specific protein binding (antibody) and can be produced in a microenvironment at the surface of the probe.
  • the light output is then measured by photon measuring devices in the formulation of homogeneous (separation free) assays (Messeri, G. et al . , Clin . Chem . 30:653-657 (1984); Sutherland, R.M. et al . , Complementary Immunoa ⁇ say ⁇ , Collins, W.P., ed., (John Wiley & Sons, Ltd.) pp. 241-261 (1988)).
  • PEVP poly-N-ethyl-4-vinylpyridinium bromide
  • Luminescent capillary electrophoresi ⁇ gels, gel transfer ⁇ or blots are examples of techniques which provide quantitative measurement of proteins and nucleic acid genetic material. These techniques can be used in conjunction with ethod ⁇ which amplify analyte expre ⁇ sion, e .g. , probes, PCR (polymera ⁇ e chain reaction) band ⁇ , RFLP (restriction fragment length polymorphisms) methods and other method ⁇ which amplify gene expre ⁇ ion and other analyte ⁇ (Steven ⁇ on, R. , Biotech . Lab . 8:4-6 (1990)).
  • One aspect of the invention is the method for detecting the presence of a biacridine luminescent derivative in a sample.
  • the method comprises contacting the sample with a signal ⁇ olution to produce, by mean ⁇ of chemilumine ⁇ cence, mea ⁇ urable emitted light and mea ⁇ uring the emitted light with a photometric in ⁇ trument or device.
  • Another aspect of thi ⁇ invention i ⁇ methods for the ⁇ ynthesi ⁇ of lumine ⁇ cent derivatized 10,10'- substituted-9,9'-biacridine molecules which can be bound to an analyte or to a binding partner of an analyte or to a ligand of a binding partner to an analyte. These molecules may have additional substitutions at other sites on the molecule such as carbon atom ⁇ one through eight.
  • Still another a ⁇ pect of the invention i ⁇ directed to a chemilumine ⁇ cent system for emitting measurable light useful in a chemical a ⁇ ay, a ligand binding assay, an im unoassay or a nucleotide a ⁇ ay.
  • the sy ⁇ tem comprises, at a pH ranging from about 10.0 to about 14.0, a 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine with a ⁇ pecific energy of activation and oxidation potential, bound to an analyte, or to a binding partner of an analyte or to a ligand of a binding partner to an analyte and an oxidant or a combination of oxidant ⁇ capable of overcoming the inherent oxidation potential of the biacridine.
  • the biacridine acts as a luminescent label (trigger or tag) for the production of chemiluminescence in chemical as ⁇ ay ⁇ , homogeneous, heterogeneous competitive and sandwich immunoa ⁇ says, ligand binding a ⁇ ay ⁇ and nucleotide as ⁇ ay ⁇ .
  • the light i ⁇ produced upon expo ⁇ ure of the biacridine label to a ⁇ ignal solution having the nucleophilic reactant ⁇ and oxidant or oxidant ⁇ .
  • the 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridines are e ⁇ pecially beneficial a ⁇ the label i ⁇ more ⁇ en ⁇ itive (i.e., detect ⁇ ⁇ maller quantitie ⁇ of analyte) than known chemilumine ⁇ cent label ⁇ and are able to undergo modification of the kinetic ⁇ of light production through manipulation of the ⁇ ignal ⁇ olution formula re ⁇ ulting in ⁇ table light producing kinetics for at least 0.1 ⁇ econd and al ⁇ o for a ⁇ long as 6 second ⁇ .
  • a further a ⁇ pect of the invention i ⁇ a method for the ⁇ ynthesi ⁇ of novel 10-sub ⁇ tituted biacridine ⁇ which have powerful lumine ⁇ cent propertie ⁇ .
  • This method involves the esterification of the ⁇ ub ⁇ tituent, the alkylation of the starting material (acridone) , dimerization of thi ⁇ molecule and derivatization (if nece ⁇ sary) with N-Hydroxysuccinimide.
  • Another a ⁇ pect of the invention i ⁇ a chemilumine ⁇ cent ⁇ ignal ⁇ olution which when reacted with a chemiluminescent label that is a luminescent molecule produce ⁇ chemiluminesence.
  • the ⁇ ignal solution co prise ⁇ at a pH from about 10.0 to about 14.0, 0.02 M ⁇ odium tetraborate (borax) , ethylenediaminetetra- acetic acid (EDTA) , dimethyl ⁇ ulfoxide (DMSO) , D(-) fructose, potassium superoxide (K0 2 ) and 2-Methyl-2- propanol.
  • the reaction will produce a signal to noise photon emis ⁇ ion ratio of at lea ⁇ t 20:1 at 1 ng/ml of label concentration for at least 0.1 seconds duration.
  • the ⁇ ignal ratio can be 50:1, 100:1,
  • the emis ⁇ ion can also be manipulated to last up to 6 seconds or longer.
  • this ⁇ ignal ⁇ olution can trigger acridinium derivative, lucigenin and 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine chemilumine ⁇ cence producing a ⁇ ignificant increa ⁇ e in light output and a change in light output kinetic ⁇ from the output obtained with previou ⁇ ly known ⁇ ignal solutions.
  • Fig. 1 is a histogram that repre ⁇ ent ⁇ the re ⁇ ult ⁇ of an experiment which compare ⁇ the relative chemilumine ⁇ cence of the signal reagent (zero) , lucigenin and 10,10'-para-toluic acid-9,9'-biacridine when flashed with the signal solution of the invention.
  • Fig. 2 is a chart representing the results from a ⁇ canning spectrophotometric measurement of the label of the invention when conjugated to antibody.
  • Fig. 3 is a curve repre ⁇ entating the linearity of ⁇ ignal obtained when fla ⁇ hing a 10,lO'- ⁇ ub ⁇ tituted- 9,9'-biacridine labeled antibody with the ⁇ ignal ⁇ olution of the invention.
  • Fig. 4 is a kinetic ⁇ tudy demon ⁇ trating the variability in light output kinetic ⁇ obtained with varying formulation ⁇ of the ⁇ ignal reagent of the invention.
  • Fig. 5 i ⁇ a ⁇ chematic flow diagram of a preferred method for synthesizing the N-Hydroxysuccinimide derivative of 10,lO'-para-toluic acid-9,9'-biacridine dinitrate.
  • a signal solution comprise ⁇ a reagent or group of reagent ⁇ which, when combined with a ⁇ pecific lumine ⁇ cent molecule or a specific luminescence mediating molecule, will cause the production of light.
  • a luminescent label is a luminescent molecule (i.e., the substance which emits light) .
  • a lumine ⁇ cent molecule i ⁇ a ⁇ ub ⁇ tance which following electronic excitation by con ⁇ tituent ⁇ of a chemical ⁇ olution, will emit a photon( ⁇ ) upon decay of orbital electron ⁇ to ground ⁇ tate.
  • a lumine ⁇ cent reactant is a free luminescent molecule (i.e., a luminescent molecule that i ⁇ not bound to an analyte, a binding partner of an analyte or to a ligand of a binding partner of the analyte) .
  • a luminescent molecule can also include the plural “luminescent molecules”.
  • the singular term “luminescence mediating molecule” can also include the plural.
  • the ⁇ ignal ⁇ olution is comprised of free molecules (i.e., not bound to an analyte, a binding partner of an analyte or to a ligand of a binding partner of the analyte) .
  • the ⁇ ingular term "lumine ⁇ cent molecule” can al ⁇ o include the plural "lumine ⁇ cent molecule ⁇ ".
  • the ⁇ ingular term "luminescence mediating molecule" can also include the plural.
  • the invention is directed to methods for synthesizing luminescent 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine derivative molecule ⁇ which can be bound to an analyte, a binding partner of an analyte, or to a ligand of a binding partner of an analyte either directly or indirectly.
  • the invention is also directed to a method for detecting in a sample the presence of a 10,10'- ⁇ ubstituted-9,9'-biacridine lumine ⁇ cent derivative having a ⁇ pecific energy of activation and oxidation potential.
  • the method compri ⁇ e ⁇ contacting the ⁇ a ple with a ⁇ ignal ⁇ olution which compri ⁇ es at least one oxidant capable of lowering the specific energy of activation or oxidation potential of the 10,10'-sub ⁇ tituted-9,9'-biacridine.
  • the 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine and the oxidant react to produce emitted light by means of chemiluminescence.
  • Postulated mechanism ⁇ for the chemilumine ⁇ cent production of light by 10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine ⁇ would begin with the addition of nucleophiles ⁇ uch a ⁇ hydroxide ions to the biacridine leading to ⁇ chi ⁇ m of the dimer between the 9,9'- carbon atom ⁇ .
  • This ⁇ chi ⁇ m produces two N- Methylacridone molecule ⁇ which can be oxidized to produce light as discussed by Janzen, et al . , Maeda, et al . , and Maskiewicz, et al . , supra .
  • Abstraction of an electron from an appropriate luminescent molecule leads to the formation of the excited intermediate which emits a photon upon decay of the lumine ⁇ cent molecule to the ground energy state .
  • the light is then mea ⁇ ured preferably with a photometric in ⁇ trument or device ⁇ uch a ⁇ the Berthold Lumat LB 950 luminometer. This method is more sensitive and more accurate due to lack of interference and self absorption problems encountered with the usual fluorometric methods used to detect fluorophores in ⁇ olution.
  • Pota ⁇ ium ⁇ uperoxide i ⁇ preferred for overcoming the oxidation potential of the 10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine.
  • pota ⁇ ium superoxide in conjunction with other oxidants such as osmium tetroxide or hydrogen peroxide, i ⁇ al ⁇ o another oxidant mixture capable of overcoming the inherent oxidation potential of the 10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine.
  • the invention i ⁇ al ⁇ o directed to a chemiluminescent system for emitting measurable light useful in a chemical as ⁇ ay, in a ligand binding a ⁇ ay ⁇ uch a ⁇ an immunoa ⁇ ay or in a nucleotide a ⁇ say.
  • This system comprise ⁇ at a pH ranging from about 10.0 to about 14.0, a 10,10'-sub ⁇ tituted-9,9'-biacridine lumine ⁇ cent derivative having an oxidation potential bound to an analyte or to a binding partner of an analyte or to a ligand of a binding partner to an analyte, and at least one oxidant which is/are capable of lowering the oxidation potential of the 10,10'-substituted-9,9'-biacridine.
  • Es ⁇ entially the 10,10'-substituted-9,9'-biacridine acts a ⁇ a label (i.e., a tag or tracer) and produce ⁇ light in the chemilumine ⁇ cent reaction.
  • the immunoa ⁇ ay may be homogeneous or heterogeneou ⁇ and a competitive or ⁇ andwich assay.
  • the light is produced by the 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine by mean ⁇ of chemilumine ⁇ cence upon expo ⁇ ure of the 10,10'- substituted-9,9'-biacridine to an oxidant or oxidant ⁇ .
  • a binding partner to an analyte in this sy ⁇ tem may be a nucleotide probe, an antibody, an antigen, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
  • a ligand used herein means a linking or binding molecule and may include an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer other than a protein ⁇ uch a ⁇ a polyhydrocarbon, a polyglyceride or a poly ⁇ accharide.
  • a particularly suitable hapten conjugate is a steroid molecule-10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine conjugate.
  • the analyte may be bound to the binding partner or the binding partner may be bound to the ligand by mean ⁇ of a biotin-avidin or a biotin- ⁇ treptavidin bridge.
  • the ligand may al ⁇ o be biotin, avidin or ⁇ treptavidin and the analyte may al ⁇ o be bound to the 10,10'-substituted-9,9'- biacridine by means of the biotin-avidin, biotin- ⁇ treptavidin ⁇ y ⁇ tem.
  • the ⁇ ystem provides great sen ⁇ itivity (up to 10 "16 to 10' 20 molar detection of antibody or antigen) when the ⁇ y ⁇ tem comprise ⁇ 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine lumine ⁇ cent label and pota ⁇ ium ⁇ uperoxide as the oxidant.
  • chemilumine ⁇ cent system will be effective at a pH ranging from about 10 to about 14, the preferred pH is from a pH of about 12.5 to 13.5.
  • the chemiluminescent propertie ⁇ of the 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine tag together with the other reagents in the system make the sy ⁇ tem particularly ⁇ uitable for the development of ultrasensitive assays for many hapten and macromolecular analytes to which the 10,10'- sub ⁇ tituted-9,9'-biacridine can be directly or indirectly conjugated such as hormones, vitamins, toxins, proteins, infectious and contagious agents, chemicals, drug ⁇ , tumor marker ⁇ , receptor ⁇ , biotin, avidin, ⁇ treptavidin and genetic material.
  • the 10,10'-substituted-9,9'-biacridine can also be directly or indirectly conjugated to a specific binding protein such as an antibody for use in chemilumino etric as ⁇ ay development.
  • the invention i ⁇ further directed to a chemiluminescent ⁇ y ⁇ tem for emitting mea ⁇ urable light u ⁇ eful in a chemical assay, an immunoas ⁇ ay, a ligand binding assay or a nucleic acid assay which comprise ⁇ a 10,10'-substituted-9,9'-biacridine having a specific oxidation potential, bound to an analyte, or to a binding partner of an analyte or to a ligand to a binding partner to an analyte and a signal solution which comprise ⁇ , at a pH ranging from about 10.0 to about 14.0, the oxidant, pota ⁇ ium ⁇ uperoxide, or a combination of oxidant ⁇ comprising osmium tetroxide and potassium superoxide.
  • Example ⁇ of lumine ⁇ cent molecule ⁇ for use with the signal solution in this invention are the acridinium derivatives, pteridines, pteridine derivative ⁇ , lucigenin, lucigenin derivative ⁇ , luciferin, luciferin derivative ⁇ , cyclic diacyl hydrazide ⁇ (luminol or i ⁇ oluminol) , an acridinium derivative such a ⁇ dimethyl acridinium e ⁇ ter or luciferin and lucigenin derivative ⁇ such as those resulting from N- hydroxy succinimide derivatizations are preferred.
  • this chemiluminescent sy ⁇ tem lends itself to heterogeneous and homogeneou ⁇ a ⁇ ays including competitive and sandwich immunoas ⁇ ay ⁇ .
  • the ⁇ en ⁇ itivity of the ⁇ ystem is extremely high when the signal ⁇ olution compri ⁇ e ⁇ the EDTA, DMSO, D(-) fructo ⁇ e, at least one oxidant, 2-Methyl-2-propanol and aqueous sodium tetraborate as described above.
  • the analyte may be a nucleic acid, an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
  • the homogeneou ⁇ a ⁇ say would involve the use of inhibitors of label luminescence such as polyion ⁇ .
  • a polycation such as poly(4-vinylpyridinium dichromate) would inhibit, for example, an unbound deuteroporphyrin IX dihydrochloride (DPIX) labeled compound while a polycation such as poly(vinylalkyl) would inhibit an unbound positively charged 10,10'-substituted-9,9'- biacridinium labeled compound.
  • DPIX deuteroporphyrin IX dihydrochloride
  • Unbound in this instance of an a ⁇ say means that if, for example, the compound is an antigen-label conjugate, it is not bound to, for example, an antibody or if the compound is an antibody-label conjugate it is not bound to an antigen, etc.
  • the invention is al ⁇ o directed to a method for u ⁇ ing a 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine in a chemilumine ⁇ cent heterogeneou ⁇ a ⁇ ay for detecting the pre ⁇ ence of dual analyte ⁇ in a ⁇ ample.
  • Suitable analyte ⁇ for detection are nucleic acid ⁇ , antibodie ⁇ , antigens, haptens, hapten conjugates, macromolecules, polymer ⁇ or protein ⁇ .
  • the method can be a chemical a ⁇ say, a nucleotide as ⁇ ay or a ligand binding a ⁇ say such as an immunoassay.
  • the method may al ⁇ o be a combination of any of the ⁇ e a ⁇ says.
  • the invention involves the conjugation of 10,10'- substituted-9,9'-biacridine tag to a fir ⁇ t analyte or to a binding partner of that analyte or to a ligand of a binding partner of that analyte and the binding of a different tag or label ⁇ uch a ⁇ a nonmetallic tetrapyrrole lumine ⁇ cent molecule or a molecule that mediates chemiluminescence such as an enzyme to a second analyte or to a binding partner of the ⁇ econd analyte or to a ligand of the binding partner of the ⁇ econd analyte.
  • the analyte ⁇ may be a polynucleotide ⁇ trand, a chemically active compound such a ⁇ chlorin e ⁇ or an immunologically active compound such as an antibody, an antigen, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
  • a binding partner to one ⁇ ite on the fir ⁇ t analyte is attached to a solid phase such as glass, polypropylene, polycarbonate or polystyrene and the, thus, coated ⁇ olid pha ⁇ e i ⁇ contacted with the ⁇ ample and second binding partner for a second ⁇ ite on the analyte.
  • the second binding partner is conjugated to the label (e . g. , the 10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine derivative) .
  • the solid phase i ⁇ wa ⁇ hed and the bound conjugate ⁇ are expo ⁇ ed to the appropriate ⁇ ignal ⁇ olution or signal solution ⁇ .
  • the ⁇ olid pha ⁇ e i ⁇ then contacted with the ⁇ ample arid with a mea ⁇ ured amount of fir ⁇ t analyte conjugated to the 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine and with a mea ⁇ ured amount of second analyte conjugated to the other lumine ⁇ cent label.
  • the ⁇ olid phase is washed to remove any unbound conjugate.
  • the washed solid phase may be ⁇ eparately treated fir ⁇ t with a ⁇ ignal ⁇ olution ⁇ pecific for only one of the two label ⁇ wherein the label and the ⁇ olution react to produce emitted light and the amount of analyte related to that specific label may be determined by mea ⁇ uring the amount of light emitted, the ⁇ olid pha ⁇ e can then be separately contacted with another chemiluminescent signal solution ⁇ pecific for the ⁇ econd label or tag relating to the other analyte whereby that label and ⁇ ignal ⁇ olution react to produce emitted light. Again, the mea ⁇ urement of the light from the ⁇ econd reaction will determine the amount of ⁇ econd analyte pre ⁇ ent in the sample.
  • the light produced a ⁇ a re ⁇ ult of the two different labels has different properties (i.e., the wavelength of light given off by means of each label may differ or the actual amount of light produced per second of reaction may differ between the two label ⁇ )
  • One can differentiate the light given off as a result of the two different labels by utilizing time resolved lumine ⁇ cent analy ⁇ is ⁇ uch a ⁇ that u ⁇ ed in fluorometry (Lovgren, T. and K.
  • a preferred lumine ⁇ cent label for the dual analyte assay with a biacridinium derivative is an acridinium derivative such as dimethyl acridinium ester or a nonmetallic tetrapyrrole but several other luminescent labels previously discussed are also suitable.
  • a preferred nonmetallic tetrapyrrole is DPIX.
  • the ⁇ ignal ⁇ olution be ⁇ t ⁇ uited for fla ⁇ hing the bound 10,10'-substituted-9,9'- biacridine comprise ⁇ at a pH from about 10.0 to about 14.0 in 0.02 borax, EDTA, DMSO, D(-) fructo ⁇ e, potas ⁇ ium ⁇ uperoxide, 2-Methyl-2-propanol and aqueous sodium tetraborate. If one of the analyte conjugates i ⁇ an enzyme labeled analyte conjugate the ⁇ ubstrate for that enzyme can be included in the signal solution.
  • the invention is directed to a chemiluminescent homogeneous as ⁇ ay for detecting dual analyte ⁇ in a ⁇ ample.
  • the ⁇ olid pha ⁇ e may additionally be coated with a lumine ⁇ cent reactant in ca ⁇ e ⁇ where a tetrapyrrole i ⁇ u ⁇ ed a ⁇ one of the label ⁇ .
  • the thu ⁇ coated ⁇ olid pha ⁇ e i ⁇ then contacted with the sample, with a known amount of one of the analytes conjugated to a I0,10'- ⁇ ub ⁇ tituted- 9,9'-biacridine label, with a known amount of the other analyte conjugated to a luminescent label other than the biacridine and with a polyion (such as poly- N-ethyl-4-vinylpyridinium bromide, poly-4- vinylpyrimidinium dichromate, polyvinylchloride, poly(vinylalcohol) , or poly(vinylbenzyl chloride) capable of inhibiting unbound biacridine luminescent label conjugate ⁇ uch as anti-TSH-10,lO'-substituted- 9,9'-biacridine by preventing the overcoming of the oxidation potential of the luminescent label of the unbound conjugate (Vlasenko, S.B.
  • the solid pha ⁇ e is then treated with a signal solution capable of either producing emitted light by means of both conjugates simultaneou ⁇ ly or ⁇ eparately contacting the ⁇ olid phase with a signal ⁇ olution specific for one label and measuring the emitted light and then separately contacting the ⁇ olid pha ⁇ e with a ⁇ ignal ⁇ olution ⁇ pecific for emitting light by mean ⁇ of the label of the other conjugate.
  • the invention i ⁇ additionally directed to a chemilumine ⁇ cent ⁇ ignal ⁇ olution which compri ⁇ e ⁇ at a pH ranging from about 10.0 to about 14.0 an aqueou ⁇ ⁇ olution of about 150 mM to about 450 mM potassium superoxide, preferrably 300 mM in a buffered solution.
  • the preferred buffer is ⁇ odium tetraborate but other ⁇ olution ⁇ ⁇ uch a ⁇ trizma ba ⁇ e and boric acid also work well.
  • the preferred luminescent molecules for use as labels in conjunction with this signal ⁇ olution are the acridinium and 10,10'- ⁇ ub ⁇ tituted-9,9'-biacridine derivative ⁇ .
  • i ⁇ oluminol alone and deuteroporphyrin IX»2HC1 in conjunction with the luminescent reactant luminol when used with the K0 2 signal solution are also suitable labels.
  • a signal to noise photon emission ratio of at least 20:1 at 1 ng/ml of label concentration is produced for at least 0.1 second ⁇ .
  • the ⁇ ignal ratio can be 50:1, 100:1 or 200:1 and greater at 1 ng/ml of label concentration using this signal solution and a variety of biacridine labeled conjugates.
  • the emis ⁇ ion can al ⁇ o be manipulated to last from up to 6 second ⁇ or longer.
  • the invention is further directed to a chemilumine ⁇ cent ⁇ ignal ⁇ olution which compri ⁇ e ⁇ at a pH from about 10.0 to about 14.0, 0.02 M aqueou ⁇ borax, EDTA, DMSO, D(-) fructose, potas ⁇ ium superoxide, and 2-Methyl-2-propanol.
  • Thi ⁇ ⁇ ignal solution can trigger 10,10'- ⁇ ub ⁇ tituted-9,9'- biacridine derivative conjugate chemilumine ⁇ cence producing a significant increase in light output and a change in light output kinetics from the output obtained with previously known signal solution ⁇ .
  • a signal to noise photon emission ratio of 500:1 at 1 ng/ml of label concentration is produced for at least 0.1 ⁇ econds (see Figure 3) .
  • the signal ratio can be 50:1, 100:1 and even 700:1 and greater at 1 ng/ml of label concentration depending upon variations in the solution and the particular labeled conjugate.
  • the emis ⁇ ion can al ⁇ o be manipulated to la ⁇ t from up to 6 ⁇ econd ⁇ or longer.
  • the invention i ⁇ directed to a signal solution which comprises, at a pH ranging from about 10.0 to about 14.0, in an aqueous borax solution, EDTA, DMSO, D(-) fructose, potas ⁇ ium superoxide and 2-Methyl-2-propanol.
  • a signal solution which comprises, at a pH ranging from about 10.0 to about 14.0, in an aqueous borax solution, EDTA, DMSO, D(-) fructose, potas ⁇ ium superoxide and 2-Methyl-2-propanol.
  • the luminescent reactant When this solution is reacted with a lumine ⁇ cent label ⁇ uch a ⁇ a 10,10'- ⁇ ubstituted-9,9'-biacridine, the luminescent reactant produces a signal to noise photon emission ratio of at least 300:1 at 1 ng/ml of luminescent label. Again, depending upon the label the signal ratio can be 50:1, 100:1, 200:1, etc . at 1 ng/ml of label concentration.
  • the emis ⁇ ion can also be manipulated to last from up to 6 second ⁇ or longer.
  • a methyl e ⁇ ter of a ⁇ ub ⁇ tituent molecule wa ⁇ ⁇ ynthe ⁇ ized for covalent attachment at the 10- carbon atom of acridone.
  • a substituent molecule for derivatizing biacridine molecule a ⁇ u ⁇ ed herein i ⁇ a molecule having a functional group that provides for the further derivatization of the biacridine or for the attachment of the biacridine to other molecules ⁇ uch a ⁇ antigens, antibodies, etc .
  • the ⁇ ub ⁇ tituent molecule used in the course of the invention has a molecular weight of about 10,000 or less.
  • the methyl e ⁇ terification of the ⁇ ub ⁇ tituent molecule alpha-bromo-para-toluic acid wa ⁇ carried out.
  • a good example of another ⁇ ubstituent molecule of this type is iodoacetic acid.
  • Esterification wa ⁇ accomplished by reacting the sub ⁇ tituent molecule in 10% boron trifluoride in methanol (25 ml of boron trifluoride-methanol per gram of ⁇ ub ⁇ tituent molecule wa ⁇ preferably added. Thi ⁇ wa ⁇ allowed to react for at lea ⁇ t 10 hour ⁇ at room T° and the methyl ester wa ⁇ extracted with methylene chloride in a ⁇ eparation funnel. The extract wa ⁇ washed twice with H 2 0, once with 0.1 M sodium bicarbonate and twice again with H 2 0. The volume was reduced to drynes ⁇ at 60°C on a rotavapor RE120 rotary evaporator. Alternate method ⁇ of methyl e ⁇ ter ⁇ ynthesi ⁇ are the use of ether followed by the addition of diazomethane and the use of methanol containing 5% concentrated ⁇ ulfuric acid.
  • the impurities remained in the aqueou ⁇ phase.
  • the methylene chloride extract wa ⁇ then eluted and purified on a silica-60 column with 3% ethyl acetate in methylene chloride.
  • the acridone-10-para-toluic acid methyl e ⁇ ter wa ⁇ eluted and contained within the first yellow band.
  • Thi ⁇ material was again concentrated on a rotaevaporator with replacement of the ethyl acetate- ethylene chloride eluant by methanol (through a continuous feed tube on the rotaevaporator) .
  • the purified acridone-10- ⁇ ub ⁇ tituent methyl e ⁇ ter precipitated a ⁇ a light yellow cry ⁇ talline material.
  • Acridone-10-sub ⁇ tituted intermediate ⁇ (e.g., acridone-10-acetic acid) were also directly synthesized by mixing well together 8.45 g of 2- chlorobenzoic acid, 7.80 g N-phenylglycine, 11.00 g anhydrous potas ⁇ ium carbonate and 0.30 g Cu++ powder in 6 ml H 2 0. Thi ⁇ mixture wa ⁇ then refluxed overnight over an oil bath at 160°C. Ethanol wa ⁇ added slowly and the product wa ⁇ dissolved in water, filtered and ppt. with HC1. The whole mixture was refiltered to remove unconsumed 2-chlorobenzoic acid and the remaining oil in that filtrate allowed to cry ⁇ talize.
  • acridone-10- acetic acid were also ⁇ ynthe ⁇ ized, by refluxing a mixture of 500 g (2.7 mM) acridone, 130 mg 80% NaH in mineral oil and 50 ml anhydrou ⁇ THF under argon for 2-4 hour ⁇ . Iodoacetic acid (540 mg, 2.7 mM) wa ⁇ then added and refluxing of the mixture wa ⁇ continued under argon for an additional 10 hour ⁇ . The ppt. wa ⁇ filtered and the filtrate wa ⁇ purified on a reverse phase column under 20-30% ethanol elution. Thi ⁇ purified material wa ⁇ then dried and taken up in THF and hydrolyzed with 4 N NaOH for 10 hour ⁇ . Water was added and the mixture was filtered.
  • the filter was washed with H 2 0, and the mixture was brought to a pH of 8.0 with 1 N HCl.
  • Final purification was performed on reverse phase silica gel column with 10 to 30% methanol in water.
  • the product wa ⁇ collected by centrifugation and wa ⁇ hed with water once. It wa ⁇ dried on a lyophylizer (yield approximately 40%) .
  • Conver ⁇ ion of the acridone-10-para-toluic acid methyl e ⁇ ter to the quaternized 9-chloro-acridine-10-para- toluic acid methyl ester was accomplished by reacting the acridone-10-sub ⁇ tituent methyl e ⁇ ter with pho ⁇ phorou ⁇ oxychloride (P0C1 3 ) .
  • P0C1 3 pho ⁇ phorou ⁇ oxychloride
  • Dimerization and de-e ⁇ terification of the 9-chloro- acridine-10-para-toluic acid methyl e ⁇ ter was accomplished by the addition of 1 g of cold zinc metal and 10 ml of freezing cold concentrated HCl/100 mg of 9-chloro-acridine-10-para-toluic acid methyl ester which was allowed to react under freezing conditions for anywhere from 1 to 10 hour ⁇ . Thi ⁇ reaction i ⁇ violent and mu ⁇ t be carried out under freezing condition ⁇ for 1-10 hour ⁇ . The ppt. was then filtered off and washed with water. Purification of the acid filtrate wa ⁇ accompli ⁇ hed on a silica gel C-18 reverse phase column.
  • the column was pretreated with methanol followed by 0.1 N nitric acid followed by 0.01 M phosphate buffer. Elution of the filtrate was first accomplished with methanol in 0.01 M phosphate buffer to remove the byproducts, unreacted materials and salts.
  • Thi ⁇ antibody-10,10'- ⁇ ubstituted-9,9'-biacridine conjugate was purified on a 20 cm Biogel P-10 column (BioRad; Hercules, CA) by eluting with a buffer containing 10 mM dibasic potassium phosphate and 0.1 M NaCl at a pH of 7.4.
  • the antibody conjugate eluted in the first fraction off the column which can be monitored by TLC and ⁇ pectrophotometry.
  • the antibody conjugate had two ⁇ pectrophotometric peak ⁇ at 365 nm (small peak for the label) and at 275 nm for the antibody and was succe ⁇ sfully flashed with the signal solution of the invention described in Example 2 re ⁇ ulting in very rapid light emi ⁇ ion kinetic ⁇ ( ⁇ ee Figure 4) .
  • a mildly acidic environment (0.01 N HN03) ⁇ tabilizes the labels and also gives the ⁇ tronge ⁇ t ⁇ ignal to noi ⁇ e ratio.
  • a wa ⁇ h ⁇ olution containing 0.2 microliter ⁇ Tween-20/ml PSS brought to 0.01 N with HN03 should work well in separation-required assays. Exposing the label to 5 microliters of the final wash ⁇ olution ju ⁇ t before fla ⁇ hing may al ⁇ o enhance the signal.
  • this example compared the signal obtained with signal solution only (Bar 1), a 1.9 nanomolar concentration of lucigenin in distilled H 2 ⁇ (Bar 2), and a 1.3 nanomolar concentration of 10,10'- para-toluic acid-9,9'-biacridinium dinitrate in distilled H 2 0 (Bar 3) .
  • the ⁇ ignal ⁇ olution wa ⁇ prepared according to Example 2 , infra .
  • the condition ⁇ for this as ⁇ ay were the addition of 300 microliters of ⁇ ignal ⁇ olution to 5 ⁇ l of water in triplicate to 12 X 75 mm poly ⁇ tyrene tubes (VWR Scientific Inc., Philadelphia, PA) to obtain the zero signal.
  • the signal of each chemiluminescent molecule wa ⁇ obtained by fla ⁇ hing 5 ⁇ l of the diluted label with 300 ⁇ l of ⁇ ignal ⁇ olution in triplicate in a Berthold Lumat.
  • this example demonstrated the chemiluminescent functionality of the antibody conjugate and the linearity of signal with increasing dilution ⁇ .
  • the anti-TSH-10,10'-para-toluo-9,9'- biacridine conjugate was diluted from 10' 9 g/ml to 10' 18 g/ml and 5 ⁇ l of each dilution was flashed with 200 ⁇ l of signal reagent in triplicate in a Berthold
  • the re ⁇ ult ⁇ were a ⁇ follow ⁇ : 10" 9 g/ml-12,000,000 counts/sec; 10" 12 g/ml- 570,000 counts/sec; 10 '13 g/ml-37,119 count ⁇ / ⁇ ec; 10 "14 g/ml-3,510 counts/sec; 10' 15 g/ml-556 count ⁇ / ⁇ ec; 10' 16 g/ml-304 count ⁇ /sec; 10" ,7 g/ml-240 counts/ ⁇ ec; 10' ,8 g/ml-229 count ⁇ /sec; 0.0g/ml-102 counts/sec.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The synthesis of 10,10'-substituted-9,9'-biacridine molecules and their derivatives is disclosed. These molecules are shown to catalyze the production of light by chemiluminescence in the presence of a signal solution having at a pH from about 10.0 to about 14.0, at a concentration effective for producing a chemiluminescent signal, a chelating agent, a sulfoxide, a reducing sugar, an oxidant or combination of oxidants, an alcohol and aqueous sodium tetraborate. These 10,10'-substituted-9,9'-biacridines are used alone or attached to haptens or macromolecules and are utilized as labels in the preparation of chemiluminescent, homogeneous or heterogeneous assays. They are also used in conjunction with other chemiluminescent label molecules to produce multiple analyte chemiluminescent assays.

Description

PREPARATION OF DERIVATIZED
10,10'-SUBSTITUTED-9 , 9 '-BIACRIDINE
LUMINESCENT MOLECULES AND SIGNAL SOLUTIONS
Technical Field
The present invention relates to the synthesis of new 10,10'-substituted-9, /-biacridinium derivatives, the preparation of novel chemical solutions for the production of light from these new molecules, and the use of these new molecules in luminescent reactions and assays. More particularly, the invention describes the synthesis of the N-Hydroxysuccinimide derivative of 10,lO'-para-toluic acid-9,9'-biacridine and the demonstration of the ability to covalently bind (conjugate) this new molecule to another molecule such as an antibody and to produce measurable light from this bound chemiluminescent label molecule. The invention further involves a luminescent signal solution comprising at least one oxidant, a sulfoxide, a chelating agent, a reducing sugar, and an alcohol in aqueous sodium tetraborate to produce high yield photon emissions useful in chemical assays, nucleic acid assays and immunoassayε. Back round of the Invention
Measurement of light energy is becoming a very attractive method for monitoring the presence or concentration of substances in various media. Numerous bioluminescent and chemiluminescent reaction systems have been devised (Schroeder, et al . , Methods in Enzy ology 27:24-462 (1978); Zeigler, M.M. , and T.O. Baldwin, Current Topics In Bioenergetics , D. Rao Sanadi ed. , (Academic Press) pp. 65-113 (1981) ; DeLuca, M. , Non-Radio etric Assays: Technology and Application in Polypeptide and Steroid Hormone Detection , (Alan R. Liss, Inc.) pp. 47-60 and 61-77 (1988); DeJong, G.J. , and P.J.M. Kwakman, J . of Chromatography 492:319-343 (1989); McCapra, F. et al . , J. Biolumin . Chemilumin . 4:51-58 (1989);
Diamandis, E.P. , Clin . Biochem . 23:437-443 (1990); Gillevet, P.M., Nature 348:657-658 (1990); Kricka, L.J., Amer . Clin Lab . , Nov/Dec:30-32 (1990)).
Luminescence is the production of light by any means, including photoexcitation or a chemical reaction. Chemiluminescence is the emission of light only by means of a chemical reaction. It can be further defined as the emission of light during the reversion to the ground state of electronically excited products of chemical reactions ( oodhead, J.S. et al . , Complementary Immunoaεεays, W.P. Collins ed. , (John Wiley & Sons Ltd.), pp. 181-191 (1988)). Chemiluminescent reactions can be divided into enzyme-mediated and nonenzymatic reactions. It has been known for some time that the luminescent reactant luminol can be oxidized in neutral to alkaline conditions (pH 7.0 - 10.2) in the presence of oxidoreductase enzymes (horseradish peroxidase, xanthine oxidase, glucose oxidase) , H202, certain inorganic metal ion catalysts or molecules (iron, manganese, copper, zinc), and chelating agents, and that this oxidation leads to the production of an excited intermediate (3-aminophthalic acid) which emits light on decay to its ground state, (Schroeder, H.R. et al . , Anal . Chem . 48:1933-1937 (1976);
Simpson, J.S.A. et al.. Nature 279:646-647 (1979); Baret, A., U.S. Patent No. 4,933,276)). Other specific molecules and derivatives used to produce luminescence include cyclic diacyl hydrazides other than lu inol (e . g . , isoluminols) , dioxetane derivatives, acridinium derivatives and peroxyoxylates (Messeri, G. et al . , J. Biolum . Chemilum . 4:154-158 (1989); Schaap, A.P. et al . , Tetrahedron Lett . 28:935-938 (1987); Givens, R.S. et al . ACS Symposium Series 383 ; Luminescence
Applications, M.C. Goldberg ed. , (Amer. Chem. Soc. , Wash. D.C., pp. 127-154 (1989)). Additional molecules which produce light and have been utilized in the ultrasensitive measurement of molecules are polycyclic and reduced nitropolycyclic aromatic hydrocarbons, polycyclic aromatic amines, fluorescamine-labeled catecholamines, and other fluorescent derivatizing agents such as the coumarins, ninhydrins, o-phthalaldehydes, 7-fluoro-4- nitrobenz-2,1,3-oxadiazoles, naphthalene-2,3- dicarboxaldehydes, cyanobenz[f]isoindoles and daήsyl chlorides (Simons, S.S., Jr. and D.F. Johnson, J. Am . Chem . Soc . 98:7098-7099 (1976); Roth, M. , Anal. Chem . 43:880-882 (1971); Dunges, W., ibid , 49:442-445 (1977); Hill, D.W. et al . , ibid, 51:1338-1341 (1979); Lindroth, P. and K. Mopper, ibid, 51:1667-1674 (1979) ; Sigvardson, K.W. and J.W. Birks, ibid, 55:432-435 (1983); Sigvardson, K.W. et al . , ibid, 55:1096-1102 (1984); de Montigny, P. et al . , ibid, 59:1096-1101 (1987); Grayeski, M.L. and J.K. DeVasto, iJid, 59:1203-1206 (1987); Rubinstein, M. et al . , Anal . Biochem . 95:117-121 (1979); Kobayashi, S.-I., et al . , ibid, 112:99-104 (1981); Watanabe, Y. and K. Imai, ibid , 116:471-472 (1981); Tsuchiya, H. , J. Chromatog . 232:247-254 (1982); DeJong, C. et al . , ibid, 242:345-359 (1982); Miyaguchi, K. et al. , iiid, 303:173-176 (1984); Sigvardson, K.W. and J.W. Birks, ibid, 316:507-518 (1984); Benson, J.R. and P.E. Hare, Proc . Nat . Acad . Sci . 72:619-622 (1975); Kawasaki, T. et al . , Biomed . Chromatog. 4:113-118 (1990)).
There are currently four known nonenzymatic systems: the acridinium derivatives (McCapra et al . , British Patent No. 1,461,877; Wolf-Rogers J. et al . , J. Immunol . Methods 233:191-198 (1990)); isoluminolε, metalloporphyrins (Forgione et al . , U.S. Patent No. 4,375,972) and nonmetallic tetrapyrroles (Katsilometeε, PCT International Publication No. WO 93/23756) . These systems have certain advantages over the enzyme-mediated systems in that they have faster kinetics resulting in peak light output within seconds. The metalloporphyrins are small hapten molecules which decrease stearic hinderance problems in antigen binding. In addition, the metalloporphyrin molecules known to be luminescent are those containing a paramagnetic metal ion with emission yields above 10"4 (Gouterman, M. , The Porphyrinε , Vol. Ill, Dolphin, D. , ed. , (Academic Press): 48-50, 78-87, 115-117, 154-155 (1978); Canters, G.W and J.H. Van Der Waals, ibid, 577-578) . It has also been known that metalloporphyrins, hyposporphyrins, pseudonormal metalloporphyrins and metalloporphyrin-like molecules such as metallic chlorins, hemes, cytochromes, chlorophylls, lanthanides and actinides undergo oxidation/reduction reactions which are either primary or secondary to structural perturbations occurring in the metallic center of these molecules and that their reactive ability to catalyze the production of chemiluminescence has been ascribed to the metallo center of these molecules (Eastwood, D. and M. Gouterman, J . Mol . Spectros . 35:359-375 (1970); Fleischer, E.B. and M. Krishnamurthy, Annals N. Y. Academy of Sci . 206:32-47 (1973); Dolphin, D. et al . , ibid, 206:177-201; Tsutsui, M. and T.S. Srivastava, ibid, 206:404-408; Kadish, K.M. and D.G. Davis, ibid, 206:495-504; Felton, R.H. et al . , ibid, 206:504-516; Whitten, D.G. et al . , ibid, 206:516-533; Wasser, P.K.W. and J.-H. Fuhrhop, ibid, 206:533-549; Forgione et al., U.S. Patent No. 4,375,972; Reszka, K. and R.C. Sealy, Photochemistry and Photobiology 39:293-299 (1984); Gonsalves, A.M.d'A. R. et al. , Tetrahedron Lett . 32:1355-1358 (1991)). These reactions are altered by iron and other metal ions which may be present in the reactants and these metal ions can interfere with and greatly confound the assay of metalloporphyrin conjugate concentrations (Ewetz, L. and A. Thore, Anal . Biochem . 72:564-570 (1976)). Different metals will strongly influence the lifetimes and luminescent properties of the metalloporphyrins.
The nonmetallic porphyrin deuteroporphyrin-IX HC1 has been shown to mediate the production of light from luminol in solution (Katsilo etes, G.W. , supra) .
Use of the luminescent acridinium ester and amide derivatives in chemiluminescent reactions and in the development of nonisotopic ligand binding assays has been reported and reviewed (Weeks, I. et al., Clin . Chem. 29/8:1474-1479 (1983); Weeks, I. and J.S.
Woodhead, Trends in Anal . Chem . 7/2:55-58 (1988)). The very short lived emission of photons (< 5 sec) to produce the flash-type kinetics in the presence of H202 and NaOH oxidation reagents (pH 13.0) is characteristic of the system. Methods of preparation of acridones and variously substituted acridines and acridones have been summarized (Acridines , Acheson, R.M. and L.E. Orgel, (Interscience Publishers, N.Y.) pp. 8-33, 60-67, 76- 95, 105-123, 148-173, 188-199, 224-233 (1956)). Formation of biacridines by the combining of two acridine residues at the carbon-9 atom has been described and reviewed previously (Gleu, K. and R. Schaarschmidt, Berichte 8:909-915 (1940)). These efforts led to the synthesis of 10,10'-dimethyl,
10,10,-diphenyl and 10,10,-diethyl-9, '-biacridinium nitrate molecules'. It was also reported that these molecules will produce light when exposed to hydrogen peroxide in basic solution (Gleu, K. and W. Petsch, Angew . Chem . 48:57-59 (1935); Gleu, K. and R. Schaarschmidt, Berichte 8:909-915 (1940)).
The mechanism of light production by lucigenin (10,10'-dimethyl-9,9'-biacridinium nitrate) has been extensively studied and has been ascribed to a series of hydroxide ion nucleophilic additions to acridinium salts and their reduction products (pinacols) , culminated by the oxidation of the main end product N-methylacridone (Janzen, E.G. et al . , J. Organic Chem . 35:88-95 (1970); Maeda, K. et al . , Bui . Chem . Soc . Japan 50:473-481 (1977); Maskiewicz, R. et al . , J. Am. Chem . Soc , 202/28:5347-5354 (1979); Maskiewicz, R. et al . ibid, 202/28:5355-5364 (1979)).
Modifications and derivatizations of 10-methyl acridine at the carbon-9 atom have led to the production of several useful chemiluminescent molecules having varying degrees of stability (Law, S.-J., et al . , J. Biolum . Chemilum . 4:88-98 (1989)). These molecules produce a flash of light lasting less than five seconds when exposed to 0.5% w/v hydrogen peroxide in 0.1 mol/L nitric acid followed by a separate solution containing 0.25 mol/L sodium hydroxide.
A luminescent derivative, a luminescent derivatized molecule or a derivatized luminescent molecule as defined herein is a molecule which results from the covalent binding of a functional group or a group which changes the chemical reactivity and properties of a precursor molecule leading to the formation of a luminescent molecule suitable for conjugation to an analyte or a particular binding partner one wishes to use in assay development. A N-hydroxy succinimide derivatization of biacridines at one or both of the two 10,10' positions are the preferred luminescent derivatives of the invention. A compound or a molecule is a "derivative" of a first compound or first molecule if the derivative compound or molecule is formed (or can be formed) by reaction of the first compound or first molecule to form a new compound or new molecule either smaller or larger than the first compound or first molecule while retaining at least part of the structure of the first compound or first molecule. As used herein the term "derivative" can also include a "luminescent derivative".
Prior to this invention, synthesis of derivatized luminescent 10,10'-substituted-9,9,-biacridines has not been achieved. The previously known luminescent biacridines (e .g. , lucigenin) contain no reactive group(s) which will permit the conjugation of the molecule to another. Until now, the biacridines have been of academic interest only and have been used to study the mechanism of light production and the interactions of reactive ionic species.
The use of luminescent reactions at the surface of light conductive materials (e.g., fiber-optic bundle) is the basis of the development of luminescent sensors or probes (Blum, L.J. et al . , Anal . Lett . 22:717-726 (1988)). This luminescence may be modulated by specific protein binding (antibody) and can be produced in a microenvironment at the surface of the probe. The light output is then measured by photon measuring devices in the formulation of homogeneous (separation free) assays (Messeri, G. et al . , Clin . Chem . 30:653-657 (1984); Sutherland, R.M. et al . , Complementary Immunoaεsayε , Collins, W.P., ed., (John Wiley & Sons, Ltd.) pp. 241-261 (1988)).
It has been demonstrated that charged synthetic polymers (poly-N-ethyl-4-vinylpyridinium bromide, PEVP) can completely inhibit the production of light by charged conjugate molecules through electrostatic interactions. This has particularly been studied in the enhanced luminol chemiluminescent reaction catalyzed by the negatively charged peroxidase enzyme. Addition of low-molecular-weight electrolytes will eliminate this inhibition thereby supporting an electrostatic nature of the observed effect (Valsenko, S.B. et al . , J . Biolum . Chemilum . 4:164-176 (1989)).
Luminescent capillary electrophoresiε gels, gel transferε or blots (Southern, Western, Northern and Dot) are examples of techniques which provide quantitative measurement of proteins and nucleic acid genetic material. These techniques can be used in conjunction with ethodε which amplify analyte expreεsion, e .g. , probes, PCR (polymeraεe chain reaction) bandε, RFLP (restriction fragment length polymorphisms) methods and other methodε which amplify gene expreεεion and other analyteε (Stevenεon, R. , Biotech . Lab . 8:4-6 (1990)). It would be beneficial in improving assay sensitivity to increase the output of light obtained from chemilumineεcent reactionε by εynthesizing biacridine molecules capable of producing εuperior quantities of photo e iεεionε and by improving exiεting signal solutionε and to have novel εignal solutions which provide a greater intensity of light during chemiluminescent reactions. The ability to modulate the kinetics of light output through manipulation of the signal solution formula is particularly beneficial in tailoring assayε for a variety of uses (genetic probe, senεor, hormones, etc.).
Summary of the Invention
One aspect of the invention is the method for detecting the presence of a biacridine luminescent derivative in a sample. The method comprises contacting the sample with a signal εolution to produce, by meanε of chemilumineεcence, meaεurable emitted light and meaεuring the emitted light with a photometric inεtrument or device.
Another aspect of thiε invention iε methods for the εynthesiε of lumineεcent derivatized 10,10'- substituted-9,9'-biacridine molecules which can be bound to an analyte or to a binding partner of an analyte or to a ligand of a binding partner to an analyte. These molecules may have additional substitutions at other sites on the molecule such as carbon atomε one through eight.
Still another aεpect of the invention iε directed to a chemilumineεcent system for emitting measurable light useful in a chemical aεεay, a ligand binding assay, an im unoassay or a nucleotide aεεay. The syεtem comprises, at a pH ranging from about 10.0 to about 14.0, a 10,10'-εubεtituted-9,9'-biacridine with a εpecific energy of activation and oxidation potential, bound to an analyte, or to a binding partner of an analyte or to a ligand of a binding partner to an analyte and an oxidant or a combination of oxidantε capable of overcoming the inherent oxidation potential of the biacridine. In this system the biacridine acts as a luminescent label (trigger or tag) for the production of chemiluminescence in chemical asεayε, homogeneous, heterogeneous competitive and sandwich immunoaεsays, ligand binding aεεayε and nucleotide asεayε. The light iε produced upon expoεure of the biacridine label to a εignal solution having the nucleophilic reactantε and oxidant or oxidantε.
The 10,10'-εubεtituted-9,9'-biacridines are eεpecially beneficial aε the label iε more εenεitive (i.e., detectε εmaller quantitieε of analyte) than known chemilumineεcent labelε and are able to undergo modification of the kineticε of light production through manipulation of the εignal εolution formula reεulting in εtable light producing kinetics for at least 0.1 εecond and alεo for aε long as 6 secondε.
A further aεpect of the invention iε a method for the εynthesiε of novel 10-subεtituted biacridineε which have powerful lumineεcent propertieε. This method involves the esterification of the εubεtituent, the alkylation of the starting material (acridone) , dimerization of thiε molecule and derivatization (if neceεsary) with N-Hydroxysuccinimide.
Another aεpect of the invention iε a chemilumineεcent εignal εolution which when reacted with a chemiluminescent label that is a luminescent molecule produceε chemiluminesence. The εignal solution co priseε at a pH from about 10.0 to about 14.0, 0.02 M εodium tetraborate (borax) , ethylenediaminetetra- acetic acid (EDTA) , dimethyl εulfoxide (DMSO) , D(-) fructose, potassium superoxide (K02) and 2-Methyl-2- propanol. Where the chemilumineεcent label iε an acridinium derivative, lucigenin, a lucigenin luminescent derivative, a biacridine, a biacridinium luminescent derivative, a cyclic diacyl hydrazide or a pteridine the reaction will produce a signal to noise photon emisεion ratio of at leaεt 20:1 at 1 ng/ml of label concentration for at least 0.1 seconds duration. Depending upon the label and the variation of the concentration of the signal εolution components, the εignal ratio can be 50:1, 100:1,
200:1, 500:1, and even 700:1 and greater at 1 ng/ml of label concentration. The emisεion can also be manipulated to last up to 6 seconds or longer.
It has also been demonstrated that this εignal εolution can trigger acridinium derivative, lucigenin and 10,10'-εubεtituted-9,9'-biacridine chemilumineεcence producing a εignificant increaεe in light output and a change in light output kineticε from the output obtained with previouεly known εignal solutions.
Brief Description of the Drawings
Fig. 1 is a histogram that repreεentε the reεultε of an experiment which compareε the relative chemilumineεcence of the signal reagent (zero) , lucigenin and 10,10'-para-toluic acid-9,9'-biacridine when flashed with the signal solution of the invention. Fig. 2 is a chart representing the results from a εcanning spectrophotometric measurement of the label of the invention when conjugated to antibody.
Fig. 3 is a curve repreεentating the linearity of εignal obtained when flaεhing a 10,lO'-εubεtituted- 9,9'-biacridine labeled antibody with the εignal εolution of the invention.
Fig. 4 is a kinetic εtudy demonεtrating the variability in light output kineticε obtained with varying formulationε of the εignal reagent of the invention.
Fig. 5 iε a εchematic flow diagram of a preferred method for synthesizing the N-Hydroxysuccinimide derivative of 10,lO'-para-toluic acid-9,9'-biacridine dinitrate.
Detailed Description of the Invention
Although the words and terms in this application have their normal definitions, the following definitions apply to preferred embodiments of the invention.
As defined herein, a signal solution compriseε a reagent or group of reagentε which, when combined with a εpecific lumineεcent molecule or a specific luminescence mediating molecule, will cause the production of light. A lumineεcent label or tag aε deεcribed herein iε a εubεtance bound to an analyte, a binding partner of an analyte, or to a ligand of a binding partner of an analyte either directly (e . g. , covalently) or indirectly (e .g . , by meanε of a εpecific binding εubεtance (protein) , a biotin-avidin or biotin-streptavidin bridge) which when combined with a signal solution either produces light or causes light to be produced. A luminescent label is a luminescent molecule (i.e., the substance which emits light) .
As defined herein, a lumineεcent molecule iε a εubεtance, which following electronic excitation by conεtituentε of a chemical εolution, will emit a photon(ε) upon decay of orbital electronε to ground εtate.
Aε used herein, a lumineεcent reactant is a free luminescent molecule (i.e., a luminescent molecule that iε not bound to an analyte, a binding partner of an analyte or to a ligand of a binding partner of the analyte) . Also as uεed herein the singular term "luminescent molecule" can also include the plural "luminescent molecules". Also, as used herein, the singular term "luminescence mediating molecule" can also include the plural.
Aε uεed herein, the εignal εolution is comprised of free molecules (i.e., not bound to an analyte, a binding partner of an analyte or to a ligand of a binding partner of the analyte) . Also as used herein the εingular term "lumineεcent molecule" can alεo include the plural "lumineεcent moleculeε". Also, aε uεed herein, the εingular term "luminescence mediating molecule" can also include the plural.
The invention is directed to methods for synthesizing luminescent 10,10'-εubεtituted-9,9'-biacridine derivative moleculeε which can be bound to an analyte, a binding partner of an analyte, or to a ligand of a binding partner of an analyte either directly or indirectly. The invention is also directed to a method for detecting in a sample the presence of a 10,10'- εubstituted-9,9'-biacridine lumineεcent derivative having a εpecific energy of activation and oxidation potential. The method compriεeε contacting the εa ple with a εignal εolution which compriεes at least one oxidant capable of lowering the specific energy of activation or oxidation potential of the 10,10'-subεtituted-9,9'-biacridine. The 10,10'- εubεtituted-9,9'-biacridine and the oxidant react to produce emitted light by means of chemiluminescence. Postulated mechanismε for the chemilumineεcent production of light by 10,10'-εubεtituted-9,9'- biacridineε would begin with the addition of nucleophiles εuch aε hydroxide ions to the biacridine leading to εchiεm of the dimer between the 9,9'- carbon atomε. This εchiεm produces two N- Methylacridone moleculeε which can be oxidized to produce light as discussed by Janzen, et al . , Maeda, et al . , and Maskiewicz, et al . , supra . Abstraction of an electron from an appropriate luminescent molecule leads to the formation of the excited intermediate which emits a photon upon decay of the lumineεcent molecule to the ground energy state . The light is then meaεured preferably with a photometric inεtrument or device εuch aε the Berthold Lumat LB 950 luminometer. This method is more sensitive and more accurate due to lack of interference and self absorption problems encountered with the usual fluorometric methods used to detect fluorophores in εolution.
Potaεεium εuperoxide iε preferred for overcoming the oxidation potential of the 10,10'-εubεtituted-9,9'- biacridine. However, potaεεium superoxide in conjunction with other oxidants such as osmium tetroxide or hydrogen peroxide, iε alεo another oxidant mixture capable of overcoming the inherent oxidation potential of the 10,10'-εubεtituted-9,9'- biacridine.
The invention iε alεo directed to a chemiluminescent system for emitting measurable light useful in a chemical asεay, in a ligand binding aεεay εuch aε an immunoaεεay or in a nucleotide aεsay. This system compriseε at a pH ranging from about 10.0 to about 14.0, a 10,10'-subεtituted-9,9'-biacridine lumineεcent derivative having an oxidation potential bound to an analyte or to a binding partner of an analyte or to a ligand of a binding partner to an analyte, and at least one oxidant which is/are capable of lowering the oxidation potential of the 10,10'-substituted-9,9'-biacridine. Esεentially the 10,10'-substituted-9,9'-biacridine acts aε a label (i.e., a tag or tracer) and produceε light in the chemilumineεcent reaction. The immunoaεεay may be homogeneous or heterogeneouε and a competitive or εandwich assay. The light is produced by the 10,10'- εubεtituted-9,9'-biacridine by meanε of chemilumineεcence upon expoεure of the 10,10'- substituted-9,9'-biacridine to an oxidant or oxidantε.
Thiε εyεtem iε particularly uεeful for detecting an analyte such as a nucleic acid, an antibody, an antigen, a hapten or hapten conjugate, a macromolecule, a protein or a polymer. A binding partner to an analyte in this syεtem may be a nucleotide probe, an antibody, an antigen, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
A ligand used herein means a linking or binding molecule and may include an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer other than a protein εuch aε a polyhydrocarbon, a polyglyceride or a polyεaccharide.
A hapten conjugate aε uεed herein iε a εmall molecule (i.e., a molecule having a molecular weight of lesε than 6,000 Daltonε) that iε attached to another molecule. A particularly suitable hapten conjugate is a steroid molecule-10,10'-εubεtituted-9,9'- biacridine conjugate. The analyte may be bound to the binding partner or the binding partner may be bound to the ligand by meanε of a biotin-avidin or a biotin-εtreptavidin bridge. The ligand may alεo be biotin, avidin or εtreptavidin and the analyte may alεo be bound to the 10,10'-substituted-9,9'- biacridine by means of the biotin-avidin, biotin- εtreptavidin εyεtem. The εystem provides great senεitivity (up to 10"16 to 10'20 molar detection of antibody or antigen) when the εyεtem compriseε 10,10'-εubεtituted-9,9'-biacridine lumineεcent label and potaεεium εuperoxide as the oxidant. An even greater εenεitivity (up to 10"22 molar detection of antibody or antigen) is obtained when the syεtem compriεeε a chelating agent, DMSO, D(-) fructoεe, 2- Methyl-2-propanol, aqueouε εodium tetraborate and a combination of oxidantε capable of overcoming the oxidation potential.
While the chemilumineεcent system will be effective at a pH ranging from about 10 to about 14, the preferred pH is from a pH of about 12.5 to 13.5.
The chemiluminescent propertieε of the 10,10'- εubεtituted-9,9'-biacridine tag together with the other reagents in the system make the syεtem particularly εuitable for the development of ultrasensitive assays for many hapten and macromolecular analytes to which the 10,10'- subεtituted-9,9'-biacridine can be directly or indirectly conjugated such as hormones, vitamins, toxins, proteins, infectious and contagious agents, chemicals, drugε, tumor markerε, receptorε, biotin, avidin, εtreptavidin and genetic material. The 10,10'-substituted-9,9'-biacridine can also be directly or indirectly conjugated to a specific binding protein such as an antibody for use in chemilumino etric asεay development.
The invention iε further directed to a chemiluminescent εyεtem for emitting meaεurable light uεeful in a chemical assay, an immunoasεay, a ligand binding assay or a nucleic acid assay which compriseε a 10,10'-substituted-9,9'-biacridine having a specific oxidation potential, bound to an analyte, or to a binding partner of an analyte or to a ligand to a binding partner to an analyte and a signal solution which compriseε, at a pH ranging from about 10.0 to about 14.0, the oxidant, potaεεium εuperoxide, or a combination of oxidantε comprising osmium tetroxide and potassium superoxide.
Exampleε of lumineεcent moleculeε for use with the signal solution in this invention are the acridinium derivatives, pteridines, pteridine derivativeε, lucigenin, lucigenin derivativeε, luciferin, luciferin derivativeε, cyclic diacyl hydrazideε (luminol or iεoluminol) , an acridinium derivative such aε dimethyl acridinium eεter or luciferin and lucigenin derivativeε such as those resulting from N- hydroxy succinimide derivatizations are preferred.
Again, this chemiluminescent syεtem lends itself to heterogeneous and homogeneouε aεεays including competitive and sandwich immunoasεayε. The εenεitivity of the εystem is extremely high when the signal εolution compriεeε the EDTA, DMSO, D(-) fructoεe, at least one oxidant, 2-Methyl-2-propanol and aqueous sodium tetraborate as described above. Again, the analyte may be a nucleic acid, an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer. The homogeneouε aεsay would involve the use of inhibitors of label luminescence such as polyionε. A polycation such as poly(4-vinylpyridinium dichromate) would inhibit, for example, an unbound deuteroporphyrin IX dihydrochloride (DPIX) labeled compound while a polycation such as poly(vinylalkyl) would inhibit an unbound positively charged 10,10'-substituted-9,9'- biacridinium labeled compound. Unbound in this instance of an aεsay means that if, for example, the compound is an antigen-label conjugate, it is not bound to, for example, an antibody or if the compound is an antibody-label conjugate it is not bound to an antigen, etc.
The invention is alεo directed to a method for uεing a 10,10'-εubεtituted-9,9'-biacridine in a chemilumineεcent heterogeneouε aεεay for detecting the preεence of dual analyteε in a εample. Suitable analyteε for detection are nucleic acidε, antibodieε, antigens, haptens, hapten conjugates, macromolecules, polymerε or proteinε. Again, the method can be a chemical aεsay, a nucleotide asεay or a ligand binding aεsay such as an immunoassay. The method may alεo be a combination of any of theεe aεsays. The invention involves the conjugation of 10,10'- substituted-9,9'-biacridine tag to a firεt analyte or to a binding partner of that analyte or to a ligand of a binding partner of that analyte and the binding of a different tag or label εuch aε a nonmetallic tetrapyrrole lumineεcent molecule or a molecule that mediates chemiluminescence such as an enzyme to a second analyte or to a binding partner of the εecond analyte or to a ligand of the binding partner of the εecond analyte. The analyteε may be a polynucleotide εtrand, a chemically active compound such aε chlorin e^ or an immunologically active compound such as an antibody, an antigen, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
Generally, in the dual sandwich-type i munoasεay, a binding partner to one εite on the firεt analyte is attached to a solid phase such as glass, polypropylene, polycarbonate or polystyrene and the, thus, coated εolid phaεe iε contacted with the εample and second binding partner for a second εite on the analyte. The second binding partner is conjugated to the label (e . g. , the 10,10'-εubεtituted-9,9'- biacridine derivative) . The εame situation exists for the second analyte only the label and the binding partners are naturally different. The solid phase iε waεhed and the bound conjugateε are expoεed to the appropriate εignal εolution or signal solutionε. Generally, in a competitive aεεay, the εolid phaεe iε coated with limited concentrationε of binding partnerε εpecific for each analyte of intereεt. The εolid phaεe iε then contacted with the εample arid with a meaεured amount of firεt analyte conjugated to the 10,10'-εubεtituted-9,9'-biacridine and with a meaεured amount of second analyte conjugated to the other lumineεcent label. Following contact, the εolid phase is washed to remove any unbound conjugate. With both the sandwich-type or competitive-type assay, the washed solid phase may be εeparately treated firεt with a εignal εolution εpecific for only one of the two labelε wherein the label and the εolution react to produce emitted light and the amount of analyte related to that specific label may be determined by meaεuring the amount of light emitted, the εolid phaεe can then be separately contacted with another chemiluminescent signal solution εpecific for the εecond label or tag relating to the other analyte whereby that label and εignal εolution react to produce emitted light. Again, the meaεurement of the light from the εecond reaction will determine the amount of εecond analyte preεent in the sample.
Since the light produced aε a reεult of the two different labels has different properties (i.e., the wavelength of light given off by means of each label may differ or the actual amount of light produced per second of reaction may differ between the two labelε) , it is posεible to treat the washed phase with a signal solution which will produce light by both conjugateε εimultaneouεly, differentiate that light and eaεure the light to determine the amount of each analyte in the εample. One can differentiate the light given off as a result of the two different labels by utilizing time resolved lumineεcent analyέis εuch aε that uεed in fluorometry (Lovgren, T. and K. Petterεεon, Luminescence Immunoaεεay and Molecular Applications , Van Dyke, K. and R. Van Dyke eds., CRC Reεε, Boca Raton, Ann Arbor, Boston, MA, pp. 233-254 (1990)).
The differences in emisεion properties such aε wavelengths can alεo be utilized (Kleinerman, M. et al . , Luminescence of Organic and Inorganic Materials , Kallmann, H.P. and G.M. Spruch edε. , International Conference, New York Univerεity Waεhington Square, εponεored by Air Force Aeronautical Reεearch Laboratory, Army Reεearch Office, Curham Office of Naval Reεearch, N.Y.U., pp. 197-225 (1961)). A preferred lumineεcent label for the dual analyte assay with a biacridinium derivative is an acridinium derivative such as dimethyl acridinium ester or a nonmetallic tetrapyrrole but several other luminescent labels previously discussed are also suitable. A preferred nonmetallic tetrapyrrole is DPIX. The preferred signal solution for producing emitted light by means of the DPIX label compriεeε at a pH from about 10.0 to about 14.0, tranε,tranε-5-(4- Nitrophenyl)-2,4-pentadienal, sodium di-2-ethylhexyl sulfosuccinate, the lumineεcent reactant luminol, glucose, benzyltrimethylammonium hydroxide, cumene hydroperoxide, trisodium para periodate, potaεεium εuperoxide and EDTA. The εignal εolution beεt εuited for flaεhing the bound 10,10'-substituted-9,9'- biacridine compriseε at a pH from about 10.0 to about 14.0 in 0.02 borax, EDTA, DMSO, D(-) fructoεe, potasεium εuperoxide, 2-Methyl-2-propanol and aqueous sodium tetraborate. If one of the analyte conjugates iε an enzyme labeled analyte conjugate the εubstrate for that enzyme can be included in the signal solution.
In addition, the invention is directed to a chemiluminescent homogeneous asεay for detecting dual analyteε in a εample. In a competitive-type aεεay, the solid phaεe iε coated with a binding partner εpecific for each different analyte. The εolid phaεe may additionally be coated with a lumineεcent reactant in caεeε where a tetrapyrrole iε uεed aε one of the labelε. The thuε coated εolid phaεe iε then contacted with the sample, with a known amount of one of the analytes conjugated to a I0,10'-εubεtituted- 9,9'-biacridine label, with a known amount of the other analyte conjugated to a luminescent label other than the biacridine and with a polyion (such as poly- N-ethyl-4-vinylpyridinium bromide, poly-4- vinylpyrimidinium dichromate, polyvinylchloride, poly(vinylalcohol) , or poly(vinylbenzyl chloride) capable of inhibiting unbound biacridine luminescent label conjugate εuch as anti-TSH-10,lO'-substituted- 9,9'-biacridine by preventing the overcoming of the oxidation potential of the luminescent label of the unbound conjugate (Vlasenko, S.B. et al , J. Biolum . Chemilum . 4:164-176 (1989)). In an asεay where it is necesεary to inhibit unbound lumineεcent label antibody conjugate such aε DPIX antibody conjugate a polycation can be uεed. Following contact, the solid phaεe is then treated with a signal solution capable of either producing emitted light by means of both conjugates simultaneouεly or εeparately contacting the εolid phase with a signal εolution specific for one label and measuring the emitted light and then separately contacting the εolid phaεe with a εignal εolution εpecific for emitting light by meanε of the label of the other conjugate.
The invention iε additionally directed to a chemilumineεcent εignal εolution which compriεeε at a pH ranging from about 10.0 to about 14.0 an aqueouε εolution of about 150 mM to about 450 mM potassium superoxide, preferrably 300 mM in a buffered solution. The preferred buffer is εodium tetraborate but other εolutionε εuch aε trizma baεe and boric acid also work well. The preferred luminescent molecules for use as labels in conjunction with this signal εolution are the acridinium and 10,10'- εubεtituted-9,9'-biacridine derivativeε. However, iεoluminol alone and deuteroporphyrin IX»2HC1 in conjunction with the luminescent reactant luminol when used with the K02 signal solution are also suitable labels. When the K02 in a buffered εignal εolution iε reacted with a lumineεcent molecule εuch as 10,10'-substituted-9,9'-biacridine or a derivative thereof or a luminescent label conjugate such as estradiol 173-10,10'-substituted-9,9'-biacridine or anti-TSH-10,10'-substituted-9,9'-biacridine, a signal to noise photon emission ratio of at least 20:1 at 1 ng/ml of label concentration is produced for at least 0.1 secondε. Depending upon the label the εignal ratio can be 50:1, 100:1 or 200:1 and greater at 1 ng/ml of label concentration using this signal solution and a variety of biacridine labeled conjugates. The emisεion can alεo be manipulated to last from up to 6 secondε or longer.
The invention is further directed to a chemilumineεcent εignal εolution which compriεeε at a pH from about 10.0 to about 14.0, 0.02 M aqueouε borax, EDTA, DMSO, D(-) fructose, potasεium superoxide, and 2-Methyl-2-propanol. Thiε εignal solution can trigger 10,10'-εubεtituted-9,9'- biacridine derivative conjugate chemilumineεcence producing a significant increase in light output and a change in light output kinetics from the output obtained with previously known signal solutionε. When this solution iε reacted with a lumineεcent label or a lumineεcent label conjugate such as 10,10'-εubεtituted-9,9'-biacridine-antibody or anti- TSH-10,10'-substituted-9,9'-biacridine, a signal to noise photon emission ratio of 500:1 at 1 ng/ml of label concentration is produced for at least 0.1 εeconds (see Figure 3) . Again, the signal ratio can be 50:1, 100:1 and even 700:1 and greater at 1 ng/ml of label concentration depending upon variations in the solution and the particular labeled conjugate. The emisεion can alεo be manipulated to laεt from up to 6 εecondε or longer.
In addition, the invention iε directed to a signal solution which comprises, at a pH ranging from about 10.0 to about 14.0, in an aqueous borax solution, EDTA, DMSO, D(-) fructose, potasεium superoxide and 2-Methyl-2-propanol. It iε preferred in all aspects of the invention where this signal solution is used that it be prepared according to the procedure described in Example 2 with respect to components, εequence of component addition and component concentration. However, the componentε may be added in an altered εequence and other component concentrationε which are alεo suitable are:
- Borax: 0.005-.05 M of aqueous buffer solution
- EDTA: 0.002-0.2 mM
- DMSO: 0-8 μl/ml of the above borax buffer solution - D(-) fructose: 2-10 mg/ml of buffer solution
- Potaεsium Superoxide: 210-365 mM
- 2-Methyl-2-propanol: 0.05-0.25 ml/ml of buffer solution
When this solution is reacted with a lumineεcent label εuch aε a 10,10'-εubstituted-9,9'-biacridine, the luminescent reactant produces a signal to noise photon emission ratio of at least 300:1 at 1 ng/ml of luminescent label. Again, depending upon the label the signal ratio can be 50:1, 100:1, 200:1, etc . at 1 ng/ml of label concentration. The emisεion can also be manipulated to last from up to 6 secondε or longer.
EXAMPLE 1
Syntheεis of 10,10'-Substituted-9.9'-Biacridine Derivatives
This approach to the synthesiε of derivatized luminescent biacridine molecules included the synthesiε of acridone by the cyclisation of diphenylamine-2-carboxylic acids and N-benzoyl- diphenylamine-2-carboxylic acidε aε deεcribed by Acheson and Orgel, supra . (All chemicals and solvents can be obtained from Sigma/Aldrich, St. Louis, U.S.A. and Pacific Pac Inc., Hollister, CA) . Acridone can also be purchased from Sigma/Aldrich.
In addition to the preparation of acridone, a methyl eεter of a εubεtituent molecule waε εyntheεized for covalent attachment at the 10- carbon atom of acridone. A substituent molecule for derivatizing biacridine molecule aε uεed herein iε a molecule having a functional group that provides for the further derivatization of the biacridine or for the attachment of the biacridine to other molecules εuch aε antigens, antibodies, etc . Usually the εubεtituent molecule used in the course of the invention has a molecular weight of about 10,000 or less. In thiε example, the methyl eεterification of the εubεtituent molecule alpha-bromo-para-toluic acid waε carried out. Other moleculeε having good leaving group(ε) (such as halogen atom(s)) at one end of the molecule and the presence of functional group(s) elεewhere on the molecule, can alεo serve as subεtituent moleculeε and be εucceεsfully esterified. A good example of another εubstituent molecule of this type is iodoacetic acid. Esterification waε accomplished by reacting the subεtituent molecule in 10% boron trifluoride in methanol (25 ml of boron trifluoride-methanol per gram of εubεtituent molecule waε preferably added. Thiε waε allowed to react for at leaεt 10 hourε at room T° and the methyl ester waε extracted with methylene chloride in a εeparation funnel. The extract waε washed twice with H20, once with 0.1 M sodium bicarbonate and twice again with H20. The volume was reduced to drynesε at 60°C on a rotavapor RE120 rotary evaporator. Alternate methodε of methyl eεter εynthesiε are the use of ether followed by the addition of diazomethane and the use of methanol containing 5% concentrated εulfuric acid.
The next εtep in the εyntheεiε waε the alkylation of acridone. To accompliεh thiε, 5.4 mM of acridone and 6.5 mM of εodium hydride were added to 100 ml anhydrouε tetrahydrofuran (THF) . Thiε mixture waε then refluxed with εtirring for 2 hourε at 70°C. under argon gaε. To thiε mixture waε added 5.5 mM of the εubεtituent methyl eεter (e . g . alpha-bromo-para- toluic acid methyl eεter) and the combination waε refluxed with εtirring at 70°C. for 10-13 hourε. Silica gel thin layer chromatography (Baker Chemical Co. , Phillipεburg, PA) at thiε time with 2% methanol in methylene chloride revealed a εpot with R,=0.2 for hydrolyzed acridone-10-εubεtituent; a εecond εpot at R,=0.4 for unreacted acridone; a third εpot (very εmall) at R,=0.5 for unknown byproduct; a fourth εpot at Rr=0.6 for the acridone-10-substituent methyl eεter (acridone-10-para-toluic acid methyl eεter) ; and a fifth εpot at Rf=0.9 for unreacted substituent- methyl eεter. The reaction mixture waε a light lemon-brown color containing a precipitate (ppt.). The ppt. (containing moεtly hydrolyzed acridone-10- εubεtituent) waε filtered off and diεcarded. The filtrate waε extracted with ethyl acetate and water in a εeparation funnel to remove remaining εaltε and hydrolyzed material. The impurities remained in the aqueouε phase. The volume of the organic phase (ethyl acetate phase) was reduced to drynesε on a rotaevaporator at 60°C. Methylene chloride waε then added and the unreacted (inεoluble) acridone precipitate waε filtered off. The methylene chloride extract waε then eluted and purified on a silica-60 column with 3% ethyl acetate in methylene chloride. The acridone-10-para-toluic acid methyl eεter waε eluted and contained within the first yellow band. Thiε material was again concentrated on a rotaevaporator with replacement of the ethyl acetate- ethylene chloride eluant by methanol (through a continuous feed tube on the rotaevaporator) . The purified acridone-10-εubεtituent methyl eεter precipitated aε a light yellow cryεtalline material. This precipitate was filtered and washed with methanol (yield approximately 50%) . These molecules and their acid precursors were active fluorophores with (for examples) acridone-10-para-toluic acid and its NHS derivative exciting at 403 nm and emitting at 440 nm; and acridone-10-acetic acid and its NHS derivative exciting at 398 nm and emitting at 438 nm.
Acridone-10-subεtituted intermediateε (e.g., acridone-10-acetic acid) were also directly synthesized by mixing well together 8.45 g of 2- chlorobenzoic acid, 7.80 g N-phenylglycine, 11.00 g anhydrous potasεium carbonate and 0.30 g Cu++ powder in 6 ml H20. Thiε mixture waε then refluxed overnight over an oil bath at 160°C. Ethanol waε added slowly and the product waε dissolved in water, filtered and ppt. with HC1. The whole mixture was refiltered to remove unconsumed 2-chlorobenzoic acid and the remaining oil in that filtrate allowed to cryεtalize. The filtrate waε dissolved in NaOH, filtered, acetic acid was added and the mixture was refiltered to remove further unreacted 2- chlorobenzoic acid. The product was precipitated by the addition of HCl (acid product) and dried. Then it was extracted with excesε benzene and further purified by diεsolving in εodium acetate solution, boiling with activated charcoal and reprecipitating with HCl. The pure product waε again filtered and crystallized from dilute methanol to give a white ppt. (mp. 165-167°C). Acridone-10-εubεtituted molecules (e . g . , acridone-10- acetic acid) were also εyntheεized, by refluxing a mixture of 500 g (2.7 mM) acridone, 130 mg 80% NaH in mineral oil and 50 ml anhydrouε THF under argon for 2-4 hourε. Iodoacetic acid (540 mg, 2.7 mM) waε then added and refluxing of the mixture waε continued under argon for an additional 10 hourε. The ppt. waε filtered and the filtrate waε purified on a reverse phase column under 20-30% ethanol elution. Thiε purified material waε then dried and taken up in THF and hydrolyzed with 4 N NaOH for 10 hourε. Water was added and the mixture was filtered. The filter was washed with H20, and the mixture was brought to a pH of 8.0 with 1 N HCl. Final purification was performed on reverse phase silica gel column with 10 to 30% methanol in water. The volume waε reduced on a rotaevaporator (e . g. , RE120) and reprecipitation was carried out with 1 N HCl overnight at pH 2.5. The product waε collected by centrifugation and waεhed with water once. It waε dried on a lyophylizer (yield approximately 40%) .
Converεion of the acridone-10-para-toluic acid methyl eεter to the quaternized 9-chloro-acridine-10-para- toluic acid methyl ester was accomplished by reacting the acridone-10-subεtituent methyl eεter with phoεphorouε oxychloride (P0C13) . One milliliter of P0C13 waε added to each 50 mg of the purified methyl eεter and thiε mixture waε refluxed for 1 hour over an oil bath at 120°C.
Dimerization and de-eεterification of the 9-chloro- acridine-10-para-toluic acid methyl eεter was accomplished by the addition of 1 g of cold zinc metal and 10 ml of freezing cold concentrated HCl/100 mg of 9-chloro-acridine-10-para-toluic acid methyl ester which was allowed to react under freezing conditions for anywhere from 1 to 10 hourε. Thiε reaction iε violent and muεt be carried out under freezing conditionε for 1-10 hourε. The ppt. was then filtered off and washed with water. Purification of the acid filtrate waε accompliεhed on a silica gel C-18 reverse phase column. The column was pretreated with methanol followed by 0.1 N nitric acid followed by 0.01 M phosphate buffer. Elution of the filtrate was first accomplished with methanol in 0.01 M phosphate buffer to remove the byproducts, unreacted materials and salts. The product, (10,10'- para-toluic acid-9,9'-biacridine salt, a disubstituted biacridine) which stickε to the top of the column, waε then eluted with 30 to 90% methanol in 0.1 N nitric acid (the methanol εtrength εhould be increaεed from 30% to 90% to remove all product) . Product eluted aε a yellow band with approximately 50% methanol in 0.1 N nitric acid. The protonated purified dimer-dinitrate εalt (10,10'-para-toluic acid-9,9'-biacridinium dinitrate) waε then concentrated on a rotaevaporator at 60°C. to a εmall volume (5 ml) and waε lyophylized to dryness. Scanning εpectrophotometry on a Perkin-Elmer 552 Spectrophotometer revealed a characteriεtic abεorbance with a preliminary shoulder at 460 nm, a firεt peak at 435 nm, a second shoulder at 415 nm, a major peak at 370 nm and a trailing shoulder at 355 nm (see Figure 2) . NMR plot on a Bruker ARX 400 instrument (Rheinstetten-FO, Germany) gave a peak at 3.9 ppm indicating the preεence of the methylene carbon attached to the 10 poεition nitrogen on the dimer and the presence of multiple aromatic carbon peakε in the 7 to 9 ppm range.
Further derivatization of the dimer with N- hydroxyεuccinimide (NHS) waε accomplished by adding (with stirring) 211 micromoles (uM) of dicyclohexylcarbodiimide to 141 uM of the dimer in dry dimethylforma ide (DMF) (0.5 ml/mg of dimer). To this was added 211 uM of N-Hydroxyεuccinimide which waε allowed to react at room T° for 10 hourε. Urea precipitateε which formed during thiε reaction were filtered off. Thiε NHS-eεter of the label iε very εtable in an amber vial (at leaεt one year) . On reverεe phaεe TLC the major peak did not move on elution with 90% methanol in 0.01 M phoεphate buffer (a yellow εpot at the origin under long wavelength U.V. light), but doeε move with an Rf = 0.2 in 0.1 nitric acid/70% methanol (v/v) .
Conjugation of the 10,10'-para-toluo-NHS-9,9'- biacridinium dinitrate derivative to antibody began with the addition of 100 microliters of the DMF εolution of the derivative to 1 mg of the antibody in PBS at pH 7.4. In thiε example polyclonal antibody to the beta-chain of thyroid εtimulating hormone waε conjugated, however, any antibody, analyte, polymer or binding protein can be utilized. Thiε mixture waε allowed to react at room T° for 10 hourε and then 54 microliterε of a 1 mg/ml εolution of d-L-lysine was added to the antibody-derivative mix and was allowed to react for an additional 3 hours. This step is necesεary for occupying unreacted NHS εiteε on the lumineεcent derivative-antibody conjugate.
Thiε antibody-10,10'-εubstituted-9,9'-biacridine conjugate was purified on a 20 cm Biogel P-10 column (BioRad; Hercules, CA) by eluting with a buffer containing 10 mM dibasic potassium phosphate and 0.1 M NaCl at a pH of 7.4. The antibody conjugate eluted in the first fraction off the column which can be monitored by TLC and εpectrophotometry. The antibody conjugate had two εpectrophotometric peakε at 365 nm (small peak for the label) and at 275 nm for the antibody and was succeεsfully flashed with the signal solution of the invention described in Example 2 reεulting in very rapid light emiεεion kineticε (εee Figure 4) .
A mildly acidic environment (0.01 N HN03) εtabilizes the labels and also gives the εtrongeεt εignal to noiεe ratio. A waεh εolution containing 0.2 microliterε Tween-20/ml PSS brought to 0.01 N with HN03 should work well in separation-required assays. Exposing the label to 5 microliters of the final wash εolution juεt before flaεhing may alεo enhance the signal.
EXAMPLE 2
Preparation of Siσnal Solution
The signal εolution for the production of light from the new chemilumineεcent moleculeε waε formulated aε followε:
To each 100 ml of 0.02 M εodium tetraborate waε added the following with εtirring: a) 0.744 mg (0.02 mM) ethylenediaminetetraacetic acid (EDTA) b) 100 ul of dimethylεulfoxide (DMSO) c) 400 mg (0.02 M) D(-) fructoεe d) 1996 mg (280 mM) potaεεium εuperoxide (K02) e) 17 ml 2-Methyl-2-propanol EXAMPLE 3
Asεay Comparing 10,10'-para-toluic acid-9,9'-
Biacridinium Dinitrate and bis-N-Methylacridinium Dinitrate (Lucigenin)
As shown in Fig. 1 this example compared the signal obtained with signal solution only (Bar 1), a 1.9 nanomolar concentration of lucigenin in distilled H2θ (Bar 2), and a 1.3 nanomolar concentration of 10,10'- para-toluic acid-9,9'-biacridinium dinitrate in distilled H20 (Bar 3) . The εignal εolution waε prepared according to Example 2 , infra . The conditionε for this asεay were the addition of 300 microliters of εignal εolution to 5 μl of water in triplicate to 12 X 75 mm polyεtyrene tubes (VWR Scientific Inc., Philadelphia, PA) to obtain the zero signal. The signal of each chemiluminescent molecule waε obtained by flaεhing 5 μl of the diluted label with 300 μl of εignal εolution in triplicate in a Berthold Lumat.
EXAMPLE 4
Assay Demonstrating the Linearity of
Signal With Increasing Dilutionε of
Anti-TSH-10.10'-para-toluo-9.9'-biacridine Conjugate
Aε shown in Fig. 3 this example demonstrated the chemiluminescent functionality of the antibody conjugate and the linearity of signal with increasing dilutionε. The anti-TSH-10,10'-para-toluo-9,9'- biacridine conjugate was diluted from 10'9 g/ml to 10'18 g/ml and 5 μl of each dilution was flashed with 200 μl of signal reagent in triplicate in a Berthold
Lumat and the magnitude of the εignal waε recorded. The reεultε were aε followε: 10"9g/ml-12,000,000 counts/sec; 10"12g/ml- 570,000 counts/sec; 10'13g/ml-37,119 countε/εec; 10"14g/ml-3,510 counts/sec; 10' 15g/ml-556 countε/εec; 10'16g/ml-304 countε/sec; 10",7g/ml-240 counts/εec; 10' ,8g/ml-229 countε/sec; 0.0g/ml-102 counts/sec.
All publications and patent applications mentioned in thiε εpecification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The invention now being fully described, it will be apparent to one of ordinary skill in the art that many changes and modificationε can be made thereto without departing from the εpirit or εcope of the appended claimε.

Claims

WHAT IS CLAIMED IS:
1. A compoεition compriεing a 10,lO'-substituted- 9,9'-biacridine conjugated to an antigen, an antibody or a hapten.
2. The compoεition of Claim 1 wherein εaid 10,10'- εubεtituted-9,9'-biacridine iε a 10,10'-para-toluic acid-9,9'-biacridine, a 10,10'-para toluo-9,9'- biacridine, a 10,10'-aceto-9,9'-biacridine or a 10,10'-acetic acid-9,9'-biacridine.
3. A compoεition compriεing 10,10'-para-toluic acid-9,9'-biacridinium dinitrate.
4. A compoεition compriεing 10,10'-acetic acid- 9,9'-biacridinium dinitrate.
5. A chemilumineεcent system for emitting measurable light useful in a chemical aεεay, an immunoaεsay, a ligand binding asεay or a nucleotide assay, εaid εyεtem comprising: at a pH ranging from about 10.0 to about 14.0, a 10,10'-εubεtituted-9,9'- biacridine lumineεcent derivative having an oxidation potential, a εignal εolution having an oxidant or a combination of oxidants capable of overcoming the oxidation potential of the 10,i0'-subεtituted-9,9'- biacridine luminescent derivative, said 10,10'- substituted-9,9'-biacridine luminescent derivative being bound to an analyte, or to a binding partner of an analyte or to a ligand of a binding partner to an analyte.
6. The chemiluminescent syεtem of Claim 5 wherein the 10,10'-εubεtituted-9,9'-biacridine lumineεcent derivative iε a 10,10'-para-toluic acid-9,9'- biacridine or a 10,10'-acetic acid-9,9'-biacridine.
7. The chemilumineεcent εyεtem of claim 5 further compriεing a buffer solution, a chelating agent, a sulfoxide, a reducing sugar, and an alcohol.
8. The chemiluminescent syεtem of Claim 7 having a combination of oxidantε wherein the 10,10'- substituted-9,9'-biacridine lumineεcent derivative iε a 10,10'-para-toluic acid-9,9'-biacridine or a 10,10'-acetic acid-9,9'-biacridine, the buffer εolution iε aqueouε εodium tetraborate, the chelating agent iε EDTA, the εulfoxide iε DMSO, the reducing εugar iε D(-) fructoεe and the alcohol iε 2-Methyl-2- propanol.
9. The chemilumineεcent εyεtem of Claim 5 wherein εaid analyte iε a nucleic acid, an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
10. The chemilumineεcent εyεtem of Claim 5 wherein εaid binding partner is a nucleotide probe, an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
11. The chemiluminescent syεtem of Claim 5 wherein εaid ligand iε an antigen, an antibody, a hapten, a hapten conjugate, a macromolecule, a protein or a polymer.
12. The chemiluminescent syεtem of Claim 6 wherein said 10,10'-substituted-9,9'-biacridine luminescent derivative is bound to the analyte, the binding partner of the analyte or to the ligand of a binding partner of the analyte by means of a biotin-avidin or biotin-streptavidin bridge.
13. A chemiluminescent εyεtem for emitting meaεurable light uεeful in a chemical assay, a ligand binding asεay or a nucleic acid aεεay comprising: a 10,10'-εubεtituted-9,9'-biacridine label bound to an analyte, or to a binding partner of an analyte or to a ligand of a binding partner to an analyte, and a signal solution which compriseε at a pH ranging from about 10.0 to about 14.0 the oxidant potaεεium superoxide or a combination of oxidants comprising osium tetroxide and potaεεium εuperoxide.
14. The chemilumineεcent system of Claim 13 wherein said 10,10'-εubεtituted-9,9'-biacridine label iε
10,10'-para-toluic acid-9,9'-biacridinium dinitrate, 10,10'-para-toluo-9,9'-biacridiniu dinitrate, a 10,10'-aceto-9,9'-biacridinium dinitrate or 10,10'- acetic acid-9,9'-biacridinium dinitrate.
15. The chemilumineεcent system of Claim 13 wherein said signal solution compriseε the combination of oxidantε and further compriεes a buffer solution, a chelating agent, a εulfoxide, a reducing εugar, and an alcohol.
16. The chemilumineεcent εyεtem of Claim 13 wherein said buffer εolution iε aqueouε εodium tetraborate, the chelating agent is EDTA, the sulfoxide is DMSO, the reducing sugar is D(-) fructose and the syεtem further compriεeε the alcohol 2-Methyl-2-propanol.
17. The chemilumineεcent εyεtem of Claim 13 wherein said biacridine label is bound to the analyte, the binding partner of the analyte or to the ligand of a binding partner of the analyte by means of a biotin- avidin or biotin-εtreptavidin bridge.
18. A method for using a 10, 10'-εubεtituted-9, 9'- biacridine in a chemilumineεcent homogeneouε aεεay for detecting the preεence of or meaεuring the amount of an analyte in a εample compriεing: (a) providing a solid phaεe coated with a εpecific binding partner for said analyte;
(b) contacting εaid solid phase with said εample and with a predetermined amount of a 10,10'- εubεtituted-9,9'-biacridine-analyte conjugate, εaid 10,10'-substituted-9,9'-biacridine having an oxidation potential, and with a predetermined amount of a polyanion that prevents unbound 10,10'- substituted-9,9'-biacridine-analyte conjugate from mediating luminescence, at leaεt some of said binding partner binding to at leaεt εome of εaid 10,10'- substituted-9,9'-biacridine-analyte conjugate;
(c) contacting the εolid phase from (b) with a signal solution comprising at a pH ranging from about 10.0 to about 14.0, an oxidant that overcomeε or a combination of oxidantε that overcome the oxidation potential of the 10, 10'-εubεtituted-9,9'-biacridine in the bound 10, 10'-εubεtituted-9,9'-biacridine- analyte conjugate to emit light; and
(d) meaεuring the amount of light emitted in (c) wherein εaid amount of emitted light will be indirectly proportional to the amount of analyte present in said sample.
19. The method of Claim 18 wherein said 10,10'- substituted-9,9'-biacridine is a 10,10'-para-toluic acid-9,9'-biacridine derivative or a 10,10'-acetic acid-9,9'-biacridine derivative.
20. The method of Claim 18 wherein the signal solution further compriseε an aqueouε buffer solution, a chelating agent, a sulfoxide, a reducing sugar and an alcohol.
21. The method of Claim 18 wherein said signal solution comprises the oxidants osmium tetroxide and potaεεium superoxide and further comprises aqueous εodium tetraborate, EDTA, DMSO, D(-) fructoεe and 2- Methy1-2-propanol.
22. A method for using a 10,10'-subεtituted-9,9'- biacridine in a chemilumineεcent heterogeneous asεay for detecting the preεence of a firεt and εecond analyte in a εample comprising: (a) providing a solid phase coated with a firεt εpecific binding partner and a second specific binding partner, said first binding partner being specific for said firεt analyte and εaid εecond binding partner being εpecific for εaid εecond analyte;
(b) contacting εaid εolid phase with said εample and with a non-biacridine label-firεt analyte conjugate and a 10,10'-substituted-9, 9'-biacridine label-second analyte conjugate, at least some of said first analyte conjugate binding to at leaεt some of said first binding partner and at least some of said second analyte conjugate binding to at least some of said second binding partner;
(c) separating unbound conjugates from bound conjugates by washing εaid contacted solid phase;
(d) contacting said washed solid phaεe in (c) with either a εignal solution specific for said 10,10'-εubεtituted-9,9'-biacridine or a signal εolution specific for εaid non-biacridine label to produce light by meanε of a chemical reaction;
(e) detecting or meaεuring εaid light from εaid reaction in (d) ;
(f) contacting the εolid phaεe from (d) with a εignal εolution εpecific for εaid 10,l0'-εubεtituted- 9,9'-biacridine label, if the εignal solution in (d) was a solution specific for said non-biacridine label, or with a signal solution specific for said non-biacridine label, if the solution in (d) waε a εolution εpecific for said 10,10'-εubεtituted-9,9'- biacridine label, to produce light by meanε of a chemical reaction;
(g) detecting or meaεuring εaid light from said reaction in (f) ; and
(h) detecting said firεt and εaid εecond analyte or determining the amount of εaid firεt or εaid εecond analyte from the light detected or measured in steps (e) and (g) .
23. The method of Claim 22 wherein said 10,10'- substituted-9,9'-biacridine label is a 10,10'-para- toluic acid-9,9'-biacridinium dinitrate, a 10,10'- para-toluo-9,9'-biacridinium dinitrate, a 10,10'- aceto-9,9'-biacridinium dinitrate or a 10,10'-acetic acid-9,9'-biacridinium dinitrate.
24. The method of Claim 22 wherein the non- biacridine label is deuteroporphyrin IX-2HC1.
25. The method of Claim 24 wherein the waεhed εolid phase from (c) iε contacted in εtep (f) with εaid εignal εolution εpecific for deuteroporphyrin IX«2HC1 which comprises at a pH ranging from about 10.0 to about 14.0, trans, trans-5-(4-Nitrophenyl)-2,4- pentadienal, sodium di-2-ethylhexyl sulfosuccinate, luminol or iεolu inol, glucoεe, benzyltrimethylammonium hydroxide, cumene hydroperoxide, triεodium para periodate, and EDTA.
26. The method of Claim 23 wherein the washed phase from (c) is contacted in εtep (f) with εaid εignal εolution specific for a 10,10'-εubεtituted-9,9'- biacridine which compriseε in a εodium tetraborate aqueouε solution, EDTA, DMSO, D(-) fructose, K02, and 2-Methyl-2-propanol.
27. A chemilumineεcent εignal solution compriεing at a pH ranging from about 10.0 to about 14.0, an aqueouε buffer solution, a chelating agent, a sulfoxide, a reducing sugar, an oxidant or oxidants and an alcohol.
28. The chemiluminescent signal solution of Claim 27 further comprising osmium tetroxide.
29. The chemiluminescent solution of Claim 27 compriεing the oxidants oεmium tetroxide and potassium superoxide, aqueous εodium tetraborate, EDTA, DMSO, D(-) fructoεe and 2-Methyl-2-propanol.
30. In a ligand binding aεsay method for determining the preεence or meaεuring the concentration of an unknown amount of a bio-active analyte in a fluid εample whereby εuch presence or concentration is determined by using a label and a signal solution to produce a detectable or measurable reaction product, an improvement iε εet out compriεing uεing a 10,10'- substituted-9,9'-biacridine as the label and a mixture of EDTA, DMSO, D(-) fructoεe, K02 and 2- Methyl-2-propanol in aqueouε εodium tetraborate aε the εignal εolution.
31. In a method for detecting the preεence or amount of an analyte in a εample via a chemilumineεcent εandwich aεεay that utilizes a signal εolution and a lumineεcent molecule-labeled compound that bindε to εaid analyte or to a binding partner to said analyte or to a ligand of a binding partner of said analyte, an improvement which comprises: utilizing as εaid lumineεcent molecule-labeled compound a 10,10'-substituted-9,9'-biacridine-labeled compound, a predetermined amount of polyanion that prevents the biacridine in an unbound biacridine- labeled compound from mediating lumineεcence, and aε εaid εignal εolution a solution comprising at a pH from about 10.0 to about 14.0, EDTA, DMSO, D(-) fructose, potassium superoxide and 2-Methyl-2- propanol in an aqueous εodium tetraborate εolution.
32. A chemilumineεcent syεtem for producing meaεurable light by means of at least two different kinds of molecules and useful in a chemical assay, ligand binding asεay, immunoaεεay or nucleotide assay for detecting more than one analyte in a sample comprising at a pH ranging from about 10.0 to about 14.0, deuteroporphyrin IX»2HC1 coupled to a first analyte or to a binding partner of said firεt analyte or to a ligand of a binding partner of εaid firεt analyte, a 10,10'-εubεtituted-9,9'-biacridine lumineεcent label coupled to a εecond analyte or to a binding partner of εaid second analyte or to a ligand of a binding partner of said second analyte, a firεt εignal solution comprising a mixture of trans,tranε-5-(4-nitrophenyl)-2,4- pentadienal, εodium di-2-ethylhexyl sulfosuccinate, luminol, glucose, benzyltrimethylammonium hydroxide, cumene hydroperoxide, trisodium para periodate, potaεsium superoxide and ethylenediaminetetraacetic acid and a second signal solution comprising a mixture of EDTA, DMSO, D(-) fructose, K02 and 2-Methyl-2-propanol in aqueouε εodium tetraborate.
33. The lumineεcent system of Claim 32 further comprising a predetermined amount of a polycation.
34. The lumineεcent εyεtem of Claim 32 further compriεing a predetermined amount of a polyanion.
35. A method for preparing a 10,lO'-εubεtituted- 9,9'-biacridine derivative compriεing: (a) εyntheεizing a methyl ester of a subεtituent molecule, said substituent molecule having at leaεt one functional group;
(b) alkylating acridone by combining acridone εodium hydride, anhydrouε tetrahydrofuran and the methyl eεter from εtep (a) to form an acridone-10- εubεtituent-methyl eεter;
(c) reacting εaid acridone-10-εubεtituent- methyl ester from step (b) with phosphorouε oxychloride to form quaternized 9-chloro-acridine-10- εubεtituent-methyl ester;
(d) reacting said 9-chloro-acridine-10- εubεtituent-methyl eεter from εtep (c) with zinc metal and concentrated hydrochloric acid to form a quaternized, de-esterified, dimerized, 10,10'- subεtituent-9,9'-biacridine salt;
(e) reacting εaid biacridine εalt from εtep (d) with nitric acid to form a 10, 10'-εubεtituent-9,9'- biacridinium dinitrate, and
(f) further derivatizing εaid dimer dinitrate from εtep (e) by reacting said dimer dinitrate with a carbodiimide and an N-hydroxysuccinimide in dimethylformamide to form a biε-NHS-10, 10'- εubεtituent-9,9'-biacridinium dinitrate.
36. A compoεition compriεing biε-NHS-10,10'-para- toluo-9,9'-biacridinium dinitrate.
37. A compoεition comprising Bis-NHS-lθ,lO'-aceto- 9,9'-biacridinium dinitrate.
PCT/US1995/007966 1994-06-24 1995-06-22 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions WO1996000392A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP50334096A JP3989537B2 (en) 1994-06-24 1995-06-22 Preparation of 10,10'-substituted-9,9'-biacridine luminescent molecular derivatives and signal solutions
EP95924671A EP0766825B1 (en) 1994-06-24 1995-06-22 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions
DE69535764T DE69535764D1 (en) 1994-06-24 1995-06-22 9.9'- BIS-ACRIDINE DERIVATIVES AND SIGNAL SOLUTIONS
HK98100291A HK1001416A1 (en) 1994-06-24 1998-01-14 A composition, a chemiluminescent system and its use.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26548194A 1994-06-24 1994-06-24
US08/265,481 1994-06-24

Publications (1)

Publication Number Publication Date
WO1996000392A1 true WO1996000392A1 (en) 1996-01-04

Family

ID=23010618

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/007966 WO1996000392A1 (en) 1994-06-24 1995-06-22 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions

Country Status (9)

Country Link
US (1) US5866335A (en)
EP (1) EP0766825B1 (en)
JP (2) JP3989537B2 (en)
KR (1) KR100382399B1 (en)
CN (1) CN1201150C (en)
AT (1) ATE397214T1 (en)
DE (1) DE69535764D1 (en)
HK (1) HK1001416A1 (en)
WO (1) WO1996000392A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015892A1 (en) * 1997-06-25 2000-07-05 CLMP, Inc. Dual injector for chemiluminescence immunoanalyzing system
EP1026156A2 (en) * 1999-02-01 2000-08-09 Pierce Chemical Company Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
CA2306752C (en) * 1998-08-14 2008-11-18 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Chemiluminescent reagent and chemiluminescent analysis using the same
US7313065B2 (en) * 2003-08-05 2007-12-25 Lg Electronics Inc. Write-once optical disc, and method and apparatus for recording/reproducing management information on/from optical disc
DE102010035003B4 (en) * 2010-08-20 2015-08-06 PicoQuant GmbH. Unternehmen für optoelektronische Forschung und Entwicklung Spatially and temporally high-resolution microscopy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478817A (en) * 1977-11-17 1984-10-23 The Welsh National School Of Medicine Detecting or quantifying substances using labelling techniques
GB2233450A (en) * 1989-06-24 1991-01-09 Univ Wales Medicine Detecting or quantifying multiple analytes
EP0408463A1 (en) * 1989-07-13 1991-01-16 N.V. Innogenetics S.A. Chemiluminescent compositions, chemiluminescent processes and their uses in analytical assays

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340714A (en) * 1992-05-08 1994-08-23 Monitor Diagnostics, Inc. Use of nonmetallic tetrapyrrole molecules and novel signal solutions in chemiluminescent reactions and assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478817A (en) * 1977-11-17 1984-10-23 The Welsh National School Of Medicine Detecting or quantifying substances using labelling techniques
GB2233450A (en) * 1989-06-24 1991-01-09 Univ Wales Medicine Detecting or quantifying multiple analytes
EP0408463A1 (en) * 1989-07-13 1991-01-16 N.V. Innogenetics S.A. Chemiluminescent compositions, chemiluminescent processes and their uses in analytical assays

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF BIOLUMINESCENCE AND CHEMILUMINESCENCE, Volume 4, issued 1989, VLASENKO et al., "An Investigation on the Catalytic Mechanism of Enhanced Chemiluminescence: Immunochemical Applications of This Reaction", pages 164-176. *
JOURNAL OF PRAKT. CHEM., Volume 334, issued 1993, PAPADOPOULOS et al., "Synthesis of N,N'-Dialkyl-9, 9'-Biacridylidenes and 9,9'-Biacridinium Nitrates Containing Long Alkyl Chains", pages 633-636. *
TETRAHEDRON LETTERS, Volume 34, Number 8, issued 1993, PAPADOPOULOS et al., "Synthesis of Novel Protected Hemiaminal N-Methoxymethyl-N'-Methyl-9,9'Biacridyliden e from Lucigenin", pages 1371-1372. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015892A1 (en) * 1997-06-25 2000-07-05 CLMP, Inc. Dual injector for chemiluminescence immunoanalyzing system
EP1015892A4 (en) * 1997-06-25 2007-01-10 Quest Diagnostics Invest Inc Dual injector for chemiluminescence immunoanalyzing system
EP1026156A2 (en) * 1999-02-01 2000-08-09 Pierce Chemical Company Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation
EP1026156A3 (en) * 1999-02-01 2001-10-24 Pierce Chemical Company Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation

Also Published As

Publication number Publication date
KR100382399B1 (en) 2003-10-10
JP3989537B2 (en) 2007-10-10
EP0766825A4 (en) 2000-04-12
JP2006292771A (en) 2006-10-26
EP0766825B1 (en) 2008-05-28
ATE397214T1 (en) 2008-06-15
CN1155931A (en) 1997-07-30
HK1001416A1 (en) 1998-06-19
EP0766825A1 (en) 1997-04-09
DE69535764D1 (en) 2008-07-10
CN1201150C (en) 2005-05-11
JPH10502346A (en) 1998-03-03
US5866335A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
US4587223A (en) Method for quantitative determination of a biospecific affinity reaction
US5464741A (en) Palladium (II) octaethylporphine alpha-isothiocyanate as a phosphorescent label for immunoassays
Wu et al. A new europium β-diketone chelate for ultrasensitive time-resolved fluorescence immunoassays
WO1993023756A1 (en) Use of nonmetallic tetrapyrrole molecules and novel signal solutions in chemiluminescent reactions and assays
JP2006292771A (en) Preparation of 10,10&#39;-substituted-9,9&#39;-biachlysine dielectric and signal solution
US4375972A (en) Heterogeneous chemiluminescent immunoassays utilizing metallo porphyrin tag
JPH0648997B2 (en) Enhanced chemiluminescent reaction and diagnostic assay
JPH08510326A (en) How to detect a substance
US6258551B1 (en) Method for carrying out an immunoassay in a multiphase system
JPH0648996B2 (en) Amplified emission analysis
US5834206A (en) Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof
CN113049805B (en) Antibody compound, preparation method thereof and detection kit
CN110441531B (en) Kit for detecting procalcitonin in blood and preparation method thereof
Mantrova et al. Universal phosphorescence immunoassay
CA1135620A (en) Immunological compound attached to metallo-porphyrin tag
US20070031854A1 (en) Novel 10,10&#39;-substituted-9,9&#39;-biacridilidine luminescent molecules their preparation and uses
Strasburger et al. [56] Two-site and competitive chemiluminescent immunoassays
JP2002503812A (en) How to measure all analytes
AU582341B2 (en) Assay for immobilized reporter groups
JPH0758291B2 (en) Homogeneous method for the luminescence detection and / or measurement of an analyte in a medium in which the analyte can be present and a kit used for the method
CN109180571A (en) A kind of dipyridyl derivatives and synthetic method, purposes
Messeri et al. Luminescent immunoassay using isoluminol derivatives
Haasnoot et al. 5. Immunochemical and receptor technologies
フン・サン・チュー Immunochemical methods for mycotoxin analysis: from radioimmunoassay to biosensors
Klingler et al. Chemiluminescent labels for steroid immunoassays

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 95194681.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): CN JP KR

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1019960707400

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1995924671

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995924671

Country of ref document: EP